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1. Introduction 
 
Infections of the respiratory tract of chickens and turkeys pose a major problem to poultry farms. High 
medication costs, mortality and condemnation rates, a drop in egg production, reduction of egg shell 
quality and decreased hatchability cause a considerable economic loss and urge the development of 
improved prevention strategies. Infectious agents that cause avian respiratory disease include fungi (Akan 
et al., 2002), viruses (Alexander, 2000; Higgins, 1971; Ignjatovic et al., 2002; McFerran and Adair, 1977; 
Swayne et al., 2001) and bacteria (Blackall, 1999; da Rocha et al., 2002; Noormohammadi et al., 2002; 
Pruimboom et al., 1996). One recently identified pathogen is the bacterium Ornithobacterium 
rhinotracheale (ORT). This pathogen was discovered as an etiologic agent of respiratory infections in 
broiler chickens in South Africa in 1991 by Jan DuPreez (van Beek et al., 1994). Bacteriological 
examination of the diseased animals revealed a slow growing, pleomorphic, gram-negative rod that could 
not be classified as any of the known bacterial species (van Beek et al., 1994). Further investigation 
indicated that a Pasteurella-like bacterium isolated from ducks suffering from respiratory disease in 
Hungary in 1987, and also Riemerella anatipestifer-like strains isolated from turkeys suffering respiratory 
disease in Germany in 1991 and 1992, were identical to the South African isolates both in appearance and 
biochemical characteristics. Similar Gram-negative rods could be isolated from turkey flocks and broilers 
in The Netherlands in 1993 (Szalay et al., 2002). These animals showed signs of respiratory infection, 
growth retardation and sudden death (Hinz et al., 1994; van Beek et al., 1994). In the following years 
similar rods were isolated in association with avian respiratory disease in Belgium (Wyffels and Hommez, 
1990), Canada (Joubert et al., 1999), USA (Charlton et al., 1993), France (Leroy-Sétrin et al., 1998), 
Israel (Bock et al., 1995), England (Amonsin et al., 1997), Slovenia (Zorman-Rojs et al., 2000), Mexico 
(Soriano et al., 2003), Peru (Hung and Alvarado, 2001), Korea (Yoon et al., 2000), Japan (Sakai et al., 
2000), Jordan (El-Sukhon et al., 2002), Turkey (Erganis et al., 2002; Turan and Ak, 2002) and Egypt 
(Devriese et al., 2001). In 1994, Vandamme et al. proposed the name Ornithobacterium for this new 
genus and the species name rhinotracheale was assigned (Vandamme et al., 1994). Interestingly, 
investigations of old culture collections in Germany revealed that ORT had already been isolated from the 
respiratory tracts of turkeys in 1981 and from rooks in 1983 (Vandamme et al., 1994). It had also been 
isolated in Belgium (Wyffels and Hommez, 1990), the USA (Charlton et al., 1993) and Israel (Bock et al., 
1995) before 1990, but so far no isolates from earlier than 1981 have been reported (Hinz and Hafez, 
1997). Nowadays ORT is frequently isolated from cases of airsacculitis and purulent pneumonia in meat 
type turkeys and broiler chickens from all over the world (Odor et al., 1997; Roepke et al., 1998; Tahseen, 
1997; Travers et al., 1996; van Beek et al., 1994; van Empel and Hafez , 1999) and also from wild birds 
including partridge, pheasant, pigeon, rook, quail, duck, chukar, ostrich, goose, guinea fowl, chicken and 
turkey (Buys, 1996; Charlton et al., 1993; Devriese et al., 1995; Vandamme et al., 1994; van Empel and 
Hafez, 1999; van Empel et al., 1997). The global occurrence of the bacterium is further confirmed by the 
presence of maternally derived antibodies against ORT in eggs and day-old birds from all over the world. 
At this time, ORT has not been found to be a threat to public health. 
ORT may cause an acute contagious respiratory infection in turkeys and chickens (Roepke et al., 
1998; Tanyi et al., 1995; van Empel and Hafez, 1999; van Veen et al., 2000a; 2000b). The manifestations 
of infection such as its duration, severity, morbidity, and mortality rate, are extremely variable and appear 
aggravated by environmental factors such as poor management, inadequate ventilation, high stocking 
density, poor litter conditions, poor hygiene or concurrent infections. Nowadays ORT infections are 
recognized as a major burden to the poultry industry. However many ORT infections may still be missed, 
as conventional routine isolation methods for avian respiratory bacteria have to be changed for optimal 
isolation. 
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2. Bacteriology  
 
Detailed bacteriological examination indicated that O. rhinotracheale is a Gram-negative, non-
motile, pleomorphic, rod-shaped, non-spore forming bacterium of the rRNA superfamily V, in the 
taxonomic neighborhood of the genera Cytophaga, Riemerella, Flavobacterium, Weeksella, 
Sporocytophaga and Capnocytophaga. ORT was proposed as a separate bacterial species based on the 
phylogenetic position and various genotypic, chemotaxonomic and classical phenotypic characteristics of 
21 Gram-negative avian isolates (Vandamme et al., 1994). Most ORT strains grow under aerobic, micro-
aerophilic, and anaerobic conditions. Optimal growth occurs on 5% sheep blood agar (van Empel and 
Hafez, 1999), chocolate agar, or Columbia agar (without blood or serum) under micro-aerophilic 
conditions (5 to 10% CO2) at 37ºC. Under these conditions, ORT appears as pinpoint colonies (<1 mm in 
diameter) after 24 h of incubation. After 48 h, small, circular, butyrous, gray to gray-white colonies (1-2 
mm in diameter) are formed, sometimes with a reddish glow and always with a distinct odor similar to that 
of butyric acid. Because the colonies are very small, especially after 24 h of incubation, they can be 
masked or overgrown by large numbers of other more robust bacterial species such as E. coli (Chin and 
Droual, 1997). Addition of gentamicin and polymixin (both 5 µg/ml) to the agar plates adds to the 
isolation of ORT although at this time only 90% of ORT strains are resistant to both of these antibiotics. 
Thus sheep blood agar plates without antibiotics should always be included in the isolation procedure (van 
Empel et al., 1996). When grown in liquid media (Todd-Hewitt broth or Brain Heart Infusion broth), ORT 
will become more pleomorphic than when grown on agar and are of variable length (0.6-5 µm). The 
bacteria often form clumps that consist of up to several thousands of organisms (van Empel and Hafez, 
1999). Some strains require a nutrient-rich medium such as Todd-Hewitt or Brain Heart Infusion broth 
supplemented with serum (van Empel and Hafez, 1999). Further growth characteristics of ORT are the 
lack of growth onto MacConkey agar, Gassner agar, Drigalski agar, or Simmon’s citrate medium, and 
poor growth on TSI slants with no change in the butt or slant portions of the tube (Chin and Droual, 1997). 
Colonies are catalase-negative and oxidase-positive. ORT isolates are positive for enzymes such as 
alkaline phosphatase, esterase, esterase lipase, leucine arylamidase, valine arylamidase, cystine 
arylamidase, acid phosphatase, naphthol-AS-Bi-phosphohydrolase, α-galactosidase, β-galactosidase, α-
glucosidase and N-acetyl-β-glucosaminidase (Back et al., 1996; Charlton et al., 1993).  
  
3. Antigenic properties of O. rhinotracheale 
 
Immunological analysis of ORT strains using agar gel precipitation (AGP) and ELISA techniques 
(van Empel, 2002) with antisera raised against different ORT strains indicated the existence of up to 18 
different serotypes. The majority of isolates are of serotype A, while 97% of strains belong to one of the 
four major serotypes A, B, D and E. Serotype A is found in 95% of the isolates from chickens, while 
turkey isolates showed more serotype diversity (van Empel et al., 1997). van Empel et al.(1997) reported 
a relationship between the geographic origin and the serotype of ORT. The molecular basis of the 
serotyping is still unknown. In search for the serotype antigen, heat-stable or proteinase K antigen 
extractions showed to be suitable for serotyping of ORT isolates (Hafez and Sting, 1999), suggesting the 
carbohydrates (co)determine the serotype. Hyper-immune sera of different ORT serotypes has been used 
to differentiate distinct serotypes of ORT by Western blot analysis using isolated outer membrane proteins 
as antigens (Lopes et al., 2000).  
Immunoblots of ORT whole-cell proteins probed with sera from chickens naturally infected with ORT 
showed that the animals mounted an immune response during the natural infection. The antibodies reacted 
strongly with proteins with molecular masses of 33 and 42 kDa, and to a lesser extent with proteins of 52 
and 66 kDa (Hung and Alvarado, 2001). Antibodies could be in 100% of infected birds until 8 wk post-
infection.  
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4. Diversity of O. rhinotracheale  
 
Comparison of a large number of ORT strains by molecular DNA techniques such as 16S rRNA 
sequencing and rep-PCR typing, indicated considerable similarities at the genetic level and suggested that 
the species consists of a small group of closely related clones (Amonsin et al., 1997; Lopes et al., 2000). 
16S rRNA sequencing of a large number of strains revealed more than 99% identity, while rep-PCR 
typing yielded only six different rep-PCR types that showed only minor differences (Amonsin et al., 
1997). DNA-DNA binding values and G+C content (37-39%) also showed high similarities between 
tested strains (Vandamme et al., 1994). Ribotyping of 23 French strains showed a low discriminatory 
power. Random amplified polymorphic DNA (RAPD) with OPG11 (TGCCCGTCGT) as a primer was 
able to discriminate nine RAPD types with an similarity coefficient of 82% and five RAPD types with a 
similarity coefficient of 50% (Leroy-Sétrin et al., 1998). In a study of 53 strains, the amplified fragment 
length polymorphism (AFLP) method was also found to be discriminative (van Empel and Hafez, 1999). 
At this time, no information about the ORT genome is available.  
At the protein level, SDS-PAGE analysis revealed that the total protein (TP) and outer membrane 
protein (OMP) profiles of ORT strains were relatively conserved with similarity coefficients of more than 
84% between strains of different origin and/or serotype (Amonsin et al., 1997). The predominant OMP 
bands in SDS-PAGE are the 33 kDa and 42 kDa proteins that are highly immunogenic during the natural 
infection (Hung and Alvarado, 2001; Lopes et al., 2000). Together, the DNA and protein analyses indicate 
the existence of only limited diversity among ORT strains. 
 
5. Pathogenic potential of O. rhinotracheale 
 
 Initially, ORT was considered to be a secondary pathogen as it was unable to cause disease in the 
specific pathogen-free (SPF) chickens without priming with avian respiratory viruses, mainly Newcastle 
disease (ND) virus or turkey rhinotracheitis (TRT) virus (van Empel et al., 1996; van Empel et al., 1999). 
Later, in experiments with commercial birds, airsacculitis, pneumonia and increased mortality were 
observed after aerosol, intra-tracheal, intravenous and intra-thoracic ORT challenge without viral priming 
(Ryll et al., 1997; Sprenger et al., 1998). Furthermore, intravenous challenge of SPF birds with ORT did 
result in clinical disease such as meningitis and osteitis with up to 20% mortality (Goovaerts et al., 1998). 
In 2000, van Veen et al. (2000b), finally did succeed to demonstrate that ORT is capable to induce 
respiratory lesions in SPF chickens after aerosol challenge without previous priming with virus. This 
classified ORT as a primary pathogen although it is evident that the establishment of disease is promoted 
by pre-existing viral infections. In field cases, bacteria such as Bordetella avium and E. coli have also 
been suspected to promote the establishment of ORT infections but viral infections appear more important 
(DeRosa et al., 1996; Droual and Chin, 1997; Travers, 1996).  
Aerosol challenge experiments using different combinations of ORT strains and viral priming 
revealed no major differences in pathogenicity among ORT strains. In an experimental study a series of 
ORT isolates infected chickens and turkeys equally well independent of their origin or serotype (van 
Empel et al., 1996). Comparison of the pathogenicity of 18 different isolates (eight from chickens, seven 
from turkeys, two from partridges and one from a duck) also revealed comparable pathology in infected 
turkeys and broiler chickens after viral priming (van Empel and Hafez, 1999; van Empel et al., 1996). In 
another study minor differences in pathogenicity between strains isolated from South Africa and Germany 
have been reported (Travers et al., 1996; van Empel and Hafez, 1999). Similarly, van Veen et al. (2000a) 
and Travers et al. (1996) reported that Dutch isolates and a South African strain were more virulent than 
American strains of ORT.  
In the field, ORT is acquired via horizontal bird-to-bird transmission through aerosols (van Empel et 
al., 1996) or via vertical transmission. Horizontal transmission appears to be influenced by a number of 
environmental factors such as stress, inadequate ventilation, poor hygiene, and high ammonia levels (van 
Empel, 2002). Consistent with vertical transmission ORT has been reported to survive in the ovary and 
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oviduct without clinical signs (Back et al., 1996; 1998; Nagaraja et al., 1998). Furthermore, hatched 
chicks from serologically positive breeder flocks with a known history of ORT infection that were kept in 
total isolation during the investigation and that were given sterile food and water, showed positive for 
ORT after aerosol exposure to ND or TRT virus. In another study, ORT had been found on eggshells and 
yolk sacs of 1-day-old birds albeit at a low frequency (van Empel et al., 1997). These data strongly 
suggest that the egg can transmit ORT, either trans-ovarially or by cloacal contamination (van Empel et 
al., 1997).  As ORT specific antibodies can be detected in eggs and day-old chicks from all over the world, 
it is likely that the establishment of ORT infections in young birds is limited due to the presence of 
maternally derived antibodies (van Empel and Hafez, 1999).  
 
6. Diagnosis of ORT infection 
 
ORT infections are diagnosed on the basis of the clinical signs associated with the disease, ELISA 
results and/or post-mortem lesions in combination with isolation of the bacterium (Naeem et al., 2003). 
Clinical signs of ORT infection are not sufficient for diagnosis as they are rather variable and resemble to 
those of other respiratory pathogens such as E. coli or Riemerella anatipestifer, or other agents causing 
joint infections such as E. coli, Staphylococcus aureus or Streptococcus feacalis. Brain infections caused 
by ORT are most of the time not even noticed as possible cause of death and therefore easily missed.  
ORT can often successfully be isolated from diseased animals at an early stage of the infection.  
Recovery of ORT at a late stage of infection often fails (van Empel, 2002) due to the existence of 
secondary infections caused by microorganisms that grow faster and are less fastidious than ORT. In one 
study it has been reported that ORT caused 70% of the cases with respiratory symptoms in broiler 
chickens but that with bacteriology and/or serology only 30% of the cases could be connected to ORT. 
More recently, immuno-histological examination has indicated that joint-infections in turkeys can 
regularly be attributed to ORT (van Empel, 2002).  
The most frequently used method to isolate ORT in the laboratory is with use of Columbia agar plates 
enriched with blood that are placed at 37oC in a 5-10% CO2 atmosphere. ORT colonies are catalase-
negative and oxidase-positive. Gram staining will reveal characteristic pleomorphic, Gram-negative 
bacteria. Additional characterization can be done with biochemical tests, polymerase chain reaction and 
serology (Charlton et al., 1993; Vandamme et al., 1994; van Empel and Hafez, 1999). Serological tests 
that have been developed include a rapid agglutination test (RAT) (Back et al., 1998) a serum 
agglutination test (SAT), a dot immunobinding assay (DIA), and more sensitive ELISA tests (Hafez, 
1996; Lopes et al., 2002). In the ELISA, boiled-extract of ORT is often used as antigen. This method has 
been successfully applied for screening purposes and to detect maternal antibodies in day-old chickens 
and turkeys (van Empel et al., 1999). The ELISA is particularly attractive for screening as with this 
method antibodies can be detected from shortly after the start of a field infection up to 8 weeks post 
infection (Lopes et al., 2000). This is important as titers will usually peak between 1 to 4 weeks post 
infection and then rapidly decline. The serotype specificity of the ELISA is a disadvantage but 
commercial ELISA’s are available with which most serotypes can be detected. In the field, ORT infections 
suspected on the basis of serology can be confirmed with a sensitive immuno-histochemical staining of the 
infected tissues. 
 
7. Pathology associated with O. rhinotracheale infection 
 
Broilers are most susceptible to ORT infection at 3 to 4 weeks of age. Broiler breeders are most prone 
to infection between 24 to 52 weeks of age. The initial clinical signs of young chickens infected with ORT 
include relatively mild respiratory stress. In turkeys, infections in 2 week-old birds manifest as nasal 
discharge, followed by facial edema and swelling of infraorbital sinuses (Hafez, 1996). Later, birds appear 
depressed with ruffled feathers and have decreased feed and water consumption. ORT also can cause 
sudden deaths in young birds through infections of the brains and the skull, featuring totally weakened 
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skull-bones. Sometimes, a subcutaneous edema over the cranium with a severe bacterial osteitis is found 
without respiratory tract infection (Goovaerts et al., 1998).  
Older birds (>14 weeks) generally show more severe lesions (Hafez, 1996) and may develop acute 
pneumonia with mortality rates from 1 to 15%, and sometimes even up to 50% (DeRosa et al., 1996; 
1997; Tahseen, 1997). Macroscopic post-mortem examinations of these animals show a foamy, white, 
“yogurt”-like exudate in the air sacs, commonly accompanied by unilateral pneumonia. When the animals 
survive, the symptoms can disappear within one week but the situation may also deteriorate due to the 
occurrence of secondary infections.  
Another  type of ORT infection particularly in older turkeys and chickens involves the dissemination 
of the bacteria to other body sites. Frequently arthritis, osteitis and osteomyelitis develop with the 
formation of a purulent, slimy exudate in the joints of the lame birds.  
A more mild manifestation of ORT infection has been observed in flocks of turkey breeder birds. 
Here the infection manifests as a slightly increased overall mortality, a drop in egg production of 2-5% 
(Chin and Droual, 1997) and a decrease in the egg quality. Because of its relatively mild nature, this type 
of infection is probably seldom recognized as being caused by ORT (van Empel et al., 1996). 
Immunohistochemistry on experimentally infected SPF chickens one week after viral priming with 
ND and after subsequent aerosol challenge with ORT, showed that the lesions in the air sacs, lungs and, to 
a lesser extent, in the trachea are caused by ORT and not by the ND virus. At the first 2 days after ORT 
challenge, microorganisms have been found attached to the epithelium on the respiratory side of the air 
sacs. Later, the air sacs thickened, and edema and an acute granulomatous airsacculitis developed. At this 
stage, ORT and bacterial fragments have been found in abundance within single and aggregated 
macrophages. Occasionally, distinct parts of the bronchial associated lymphoid tissue (BALT) in the lungs 
became infiltrated and necrotic, while other regions of the BALT in the same lung remained unaffected. In 
general, the air-sacculitis and pneumonia induced after ORT challenge of ND primed birds were fully 
established at 5 to 7 days post-ORT challenge (van Empel et al., 1999).  
 
8. Treatment and control of ORT infections 
 
In general, bacterial infections in poultry can be successfully treated and/or controlled with anti-
microbial drugs in combination with hygienic measures. Unfortunately, most ORT strains are now 
resistant to most types of antibiotics. This resistance has likely developed as a result of intensive and 
inadequate use of antibiotics in the field as sensitive strains have been isolated from wild birds (Devriese 
et al., 2001). The anti-microbial drug sensitivity of ORT seems to vary dependent on the type of bird and 
geographical region. When ORT strains isolated from gallinaceous birds were compared with isolates 
from rooks using the agar dilution method, the minimal inhibitory concentrations for penicillin-
cephalosporin antibiotics differed 5- to 20-fold (Devriese et al., 1995). Similarly, Nagaraja et al. (1998) 
reported that the sensitivity of ORT isolates from the USA to a panel of antibiotics differed significantly 
from isolates from Germany (Lopes et al., 2000). Isolates from Europe have been found to be often 
resistant to trimethoprim / sulphonamide, gentamicin, spectinomycin, neomycin, enrofloxacin, and colistin 
(Hafez, 1996; van Beek, 1994; van Empel, 2002) but  sensitive to ampicillin, ceftiofur, doxycyline, 
lincomycin, tetracycline, chloramphenicol, amoxycillin, penicillin and tylosin (Chin and Droual, 1997; 
Devriese et al., 1995; Hafez, 1996). As in most parts of the world ORT is sensitive to doxycycline and 
tetracycline (Devriese et al., 1995; Hafez, 1996; Nagaraja et al., 1998; van Beek, 1994), administration of 
chlortetracycline via the drinking water for 4 to 5 days is often used to treat ORT infections. 
Administration of amoxicillin via the drinking water for 3 to 7 days have also been reported to give 
satisfactory results under field conditions in some regions (Hafez, 1997).  
Treatments of infected turkeys generally shows poor results with the use of conventional oral 
therapeutics, especially when pneumonia was prevalent. On some cases, injections with tetracycline and 
synthetic penicillin is an effective but often medication fails resulting in a loss of up to 25% of the animals 
within a few weeks (van Beek, 1994).  
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Adequate control of ORT infections is pursued with the use of chemical disinfectants to which most 
ORT strains are still highly sensitive (van Empel and Hafez, 1999). As ORT appears to have become 
endemic on many farms, thorough cleaning and disinfecting of houses is essential before introducing new 
stocks, especially in multiple age farms and in areas with an intensive poultry production. The most 
commonly used disinfectants are based on the antibacterial effects of different organic acids such as 
formic and glyoxyl acids, and on aldehydes that readily inactivate ORT  in vitro (van Empel, 2002). 
 
9. Vaccination against ORT infection 
 
Probably the best way to control ORT infections is by vaccination. In the past several types of 
vaccines (live attenuated bacteria, formalin-killed bacteria) have been developed and have shown promise 
for protecting at-risk chickens. Lopes et al. (2002a; 2002b) developed a temperature-sensitive (Ts) mutant 
of ORT for use as a live vaccine. This vaccine is based on the ability of the mutant to colonize the upper 
respiratory tract but not the lower respiratory tract. In turkeys, the Ts vaccine has been reported to elicit a 
secretory immune response (IgA) and to evoke a protective response against experimental ORT challenge. 
Three weeks after administration of the vaccine via the drinking water or oculo-nasal instillation, 
antibodies could be demonstrated. Vaccination with live ORT also appears to induce protection against 
ORT challenge of broilers when the maternal antibody levels were low (van Empel and van den Bosch, 
1998).  
Vaccination with formalin-killed ORT (bacterin) of broiler breeders induced long-standing immunity 
and protected their progeny against experimental challenge with ORT for 30 days (van Empel and van den 
Bosch, 1998). With double subcutaneous vaccination of 12 and 18 weeks old broilers high mean ORT 
antibody titers were obtained that remained high for the entire production period (Cauwerts et al., 2002).  
The vaccinations also caused high levels of maternal antibodies in the progeny, resulting in good 
protection against experimental challenge of the hatched broilers up to 30 days of age (van Empel and van 
den Bosch, 1998). In this study it has been observed that antibody titers in unvaccinated flocks increased 
during the study period suggesting that there was circulation of the bacterium among broiler breeders. As 
maternal immunity may protect chicks against lesions and clinical disease resulting from ORT infection up 
to the age of 4 weeks under experimental condition (van Empel and van den Bosch, 1998), vaccination 
should be started at 2-4 weeks to protect birds at older ages.  
In turkeys, both live and killed ORT vaccines have been demonstrated to protect susceptible animals 
against development of pathologic lesions. In addition, serum samples from turkeys vaccinated with live 
or killed ORT vaccines contained antibodies to the organism within 1 week of vaccination. These 
antibodies remained present for 8 weeks (bacterin) or 14 weeks (live vaccine) after vaccination (Sprenger 
et al., 2000). The most practical approach in programming a vaccine for preventing the ORT infection in 
broilers may be to vaccinate breeders with an inactivated bacterin combined with a live vaccination of 
broilers at 2-3 weeks of age. 
A major problem with the current vaccines is that they do not provide broad cross-protection against 
the various serotypes of ORT (Bock et al., 1995; 1997). Vaccination of turkey broilers with autogenous 
bacterins successfully reduced the number of outbreaks of ORT infections in the field (Bock et al., 1997). 
However, repeated infections caused by other serotypes regularly occur during the long rearing period 
(van Empel, 2002). Development of a vaccine that provide long lasting strong cross-protection against all 
ORT serotypes (van Empel and Hafez, 1999) likely awaits knowledge of the bacterial and host factors that 
are essential for the establishment of ORT infections.   
  
10. Outline of this thesis 
 
Despite the emergence of ORT as a bacterial pathogen, its wide-spread resistance towards most 
current anti-microbial drugs, its economic importance, and the limited window of protection provided by 
the available vaccines, virtually no studies have been designed to better understand the molecular basis of 
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ORT infections. For other pathogens, bacterial colonization of the mucosa and the breaching of the 
mucosal barrier either via bacterial invasion and/or the production of toxins, are crucial steps in the 
establishment of an infection. Well-known bacterial adhesins found on many bacterial pathogens are the 
hair-like structures that protrude from the bacterial cell surface (fimbriae) and cell surface adhesins (outer 
membrane proteins, lipopolysaccharide, or even capsule) that specifically interact with distinct host cell 
surface receptors. These interactions may elicit a strong inflammatory response that contributes to the 
pathology. Although ORT has been seen in close association with the respiratory epithelium and within 
macrophages in infected tissues, the mechanisms underlying these interactions as well as the nature of the 
local host cell response are still completely unknown. Up to now, no special structures such as fimbriae or 
bacterial surface adhesins have been reported for ORT (Leroy-Sétrin et al., 1998) and the basis of the host 
and tissue specificity of ORT infection, remain to be defined. Similarly, the bacterial factors that 
contribute to the potent inflammatory response and the clinical pathology observed during experimental 
and natural ORT infections (Chin and Droual, 1997; van Empel et al., 1997), await investigation.  
The work described in this thesis was designed to learn more about the molecular interaction between 
ORT and host cells in the belief that development of adequate novel infection intervention and prevention 
strategies is served best by fundamental scientific knowledge rather than by the thus far followed trial-
and-error approach.  Specific objectives were: 
1. Development of an in vitro infection model to better understand the interaction between ORT and 
mucosal epithelial cells and the kinetics of infection at the cellular level (Chapter 2). 
2. Characterization of the interaction of ORT with macrophages of different species and the induction of 
an inflammatory response using nitric oxide production as a marker of activation of the innate host 
defense (Chapter 3). 
3. Identification of host cell receptors exploited by ORT and of natural inhibitors of ORT infection 
(Chapter 4). 
4. Construction of an Escherichia coli - ORT shuttle vector to allow genetic manipulation of ORT 
(Chapter 5).    
The potential significance of the work presented in this thesis as a basis for future intervention and 
prevention of ORT infections is discussed in Chapter 6. 
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ABSTRACT 
 
The recently identified Gram-negative bacterium Ornithobacterium rhinotracheale (ORT) is an 
emerging bacterial pathogen that appears to exclusively colonize birds. ORT infections cause major 
losses to the poultry industry. In search for factors contributing to the pathogenesis of ORT infections,  
the interaction of ORT with epithelial cells was investigated. In vitro infection experiments 
demonstrated that ORT efficiently adheres to various types of cultured epithelial cells with levels up to 
80 adherent bacteria per cell at 3 h of infection. Comparison of different ORT isolates indicated that all 
tested strains exhibited adherence properties but with various characteristics. One strain switched 
between an epithelial cell and chicken red blood cell adherent phenotype, dependent on the growth 
conditions. Analysis of outer membrane profiles of adherent strains by SDS-PAGE revealed strain 
variation in both protein and lipopolysaccharide (LPS) electrophoretic mobility. Infection assays in the 
presence of LPS purified from ORT showed a LPS dose-dependent inhibition of ORT adhesion. This 
effect was strain-specific i.e. no inhibition was observed with LPS from other strains. These data 
suggest that the adhesion of ORT to epithelial cells is conferred via a unique strain-specific and LPS-
sensitive mechanism.  
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INTRODUCTION 
 
In 1994, the Gram-negative bacterium Ornithobacterium rhinotracheale (ORT) was proposed as a 
new bacterial species (Vandamme et al., 1994). The bacterium had been demonstrated to reside in a 
wide variety of domestic and wild birds, and appeared associated with bacterial respiratory disease in 
poultry. Later studies suggested that it first emerged as a pathogen at least 20 years earlier (van Empel 
and Hafez, 1999). Nowadays, ORT is a major problem to the poultry industry causing major economic 
losses due to increased mortality and condemnation rates, growth retardation, decreased egg 
production and egg shell quality, and decreased hatchability (Charlton et al., 1993; Hinz et al., 1994; 
Vandamme et al., 1994; van Empel and Hafez, 1999).  
The primary natural niche of ORT appears to be the avian respiratory tract (Hinz et al., 1994). 
From this site, the bacteria spread to the environment or to other body sites such as the brain and 
joints. Infections with ORT have been most often associated with chronic respiratory syndromes with 
severe bilateral bronchopneumonia and airsacculitis and, in some cases, pericarditis, hepatomegaly 
and arthritis. The cause of this syndrome has long been considered to be multifactorial as concurrent 
viral and bacterial infections seemed to enhance ORT pathogenicity. Challenge experiments however, 
have demonstrated that ORT can act as a primary pathogen in chicken (van Veen et al., 2000).  
The mechanisms via which ORT causes disease are largely unknown. Pathology on infected 
animals suggests that the bacteria colonize the respiratory tract of the host by adhering to the host 
mucosa. Prolonged ORT exposure is followed by influx of polymononuclear granulocytes and 
macrophages at the site of infection, a thickening of the air sacs, and the formation of granulomatous 
tissue (van Empel et al., 1999). Treatment of the disease is complicated as most isolates of ORT are 
resistant to most commonly used antibiotics. Vaccination is an effective form of infection prevention.  
Available vaccines composed of killed ORT however, are assumed to give only partial protection 
against a limited number of strains.  
A major problem in developing novel strategies to combat ORT infections is the virtually 
complete lack of knowledge about the pathogenesis of the disease. As a first step to better understand 
the initial step in the colonization, we investigated the adhesive properties of ORT towards epithelial 
cells. In vitro infection assays with cultured epithelial cells demonstrated that ORT strains efficiently 
adhere to epithelial cells. Further analysis indicated that adhesion is conferred via a strain-specific and 
LPS-sensitive mechanism.  
 
 
MATERIALS AND METHODS 
 
Bacterial strains, media and growth conditions 
ORT strains designated as 7, 29, 30 and 41 (generally provided by Dr. P. van Empel, Intervet, 
Boxmeer, The Netherlands) were isolated from infected birds. Strain 7 (serotype A) was isolated from 
guinea fowl. Strains 29 and 30 (serotype D) and strain 41 (serotype E) was isolated from turkeys. 
Bacteria were stored at -80°C in Todd-Hewitt (TH) broth (Oxoid, Hampshire, England) containing 
15% glycerol. Bacteria were grown (37°C, 48 h) on Columbia (CO) agar (Oxoid) or TH broth 
supplemented with 2% Noble agar (Difco, Detroit, USA) in a humidified atmosphere of 5% CO2 in 
air, or in 45 ml of TH broth in 50 ml polypropylene tubes on an orbital shaker (150 rpm).  
 
Cell culture 
Chang conjunctiva epithelial cells (ATCC CCL-20.2) and INT 407 intestinal epithelial cells 
(ATCC CCL-6) were routinely maintained in RPMI 1640 (Invitrogen, Paisley, UK) supplemented 
with 5% fetal bovine serum (FBS) (Bodinco B.V., Alkmaar, The Netherlands) at 37°C in a humidified 
atmosphere of 5% CO2 in air. For use in infection experiments, cells were seeded onto circular 12 mm 
glass coverslips  in 24-well tissue culture plates (Costar, New York, USA) 48 h prior to infection and 
grown to near confluence (approximately 105 cells per well), unless indicated otherwise. 
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Infection assay 
For use in infection assays, broth cultures (48 h) or solid phase grown (48 h) ORT were 
(re)suspended into Dulbecco's phosphate-buffered saline (DPBS) and added to the monolayers of 
epithelial cells maintained in 1 ml of RPMI 1640 (without serum) at a m.o.i of 100, unless indicated 
otherwise. At various times of incubation (37°C, 5% CO2), the culture medium containing non-
adherent bacteria was removed and the cells were rinsed three times with PBS. Then, the cells were 
fixed in 2% formaldehyde in  DPBS for 1 h and either stained with 0.005% crystal violet in distilled 
water for at least 3 h, or subjected to the immunogold-silverstaining procedure that allows microscopic 
discrimination of adherent and intracellular microorganisms (see below). All specimens were viewed 
in an Olympus BH-2 microscope. All experiments were repeated at least three times and data were 
statistically analyzed with the independent Student’s t-test using SPSS 9.0 software. 
 
Immunogold-Silver Staining (IGSS) procedure and fluorescence microscopy. 
The IGSS procedure is based on the inability of antibodies to diffuse into paraformaldehyde-fixed 
eukaryotic cells enabling selective immuno-staining of adherent microorganisms (van Putten, 1993).  
For use with ORT, the coverslips with the infected cells were inverted onto 100 µl drops of ORT-
serotype specific hyper-immune rabbit sera (1/1000 dilution in DPBS) placed on Parafilm for 30 min 
at 20°C. Then, the coverslips were sequentially incubated (3 x 5 min) onto 3 drops of 100 µl of DPBS 
to remove unbound antibody, and placed onto 50 µl of 10 nm gold-conjugated protein A solution. 
After an additional 30 min of incubation, the coverslips were incubated three times for 5 min onto 100 
µl drops of DPBS and two times for 5 min onto 100 ml drops of distilled water. Silver enhancement of 
the bound gold-particles was achieved by adding developing solution (composition: 70 ml of citrate 
buffer (2.55 g citric acid monohydrate + 2.35 g tri-sodium citrate dihydrate in distilled water), 15 ml of 
reducing agent (0.85 g hydroquinone) and 15 ml of silver acetate (0.11 g)) for 2-10 min. The 
coverslips were counterstained with 0.005% crystal violet and kept in this solution at 4oC until viewed 
in the microscope. For visualization of adherent bacteria in the fluorescence microscope, essentially 
the same procedure was followed except that the coverslips were incubated with goat anti-rabbit Alexa 
green  (Molecular probes, Leiden, The Netherlands) instead of gold-conjugated protein A prior to 
mounting in DPBS + 5% glycerol. 
 
Haemagglutination assay 
Haemagglutination was performed with freshly isolated chicken red blood cells (RBC) (Hsiung, 
1982) as well as  glutaraldehyde inactivated cells (Eaves et al., 1989) in PBS. RBCs were collected 
from heparinized blood derived from male White Leghorn, washed 3 times with DPBS and kept as 
10% stock suspension at 4°C until use. Glutaraldehyde fixed RBC (GA-fixed RBC) were prepared as a 
1% RBC suspension containing 1% GA solution (Polysciences, Warrington, PA) in DPBS for 30 min 
(4°C), followed by centrifugation (400 x g, 10 min, 4°C)  to remove the fixative. After five additional 
washes with 0.15 M NaCl, the cells were suspended in DPBS and stored at 4°C until further use. 
Haemagglutination (HA) was tested by mixing fifty microliters of RBC suspension (1% final 
concentration) with  an equal volume of 2-fold serial dilutions  (1:2 to 1:16) of ORT suspensions 
(5x107 cfu/ml, 48 h plate-grown or broth cultures) in DPBS in 96 well-U-shaped disposable 
microtiters plates (Costar, New York, USA). After 2 h of incubation at 20°C, HA was scored. The HA 
titer was defined as the highest dilution of bacterial suspension still capable of causing partial or 
complete hemagglutination (HA).   
 
Extraction of bacterial outer membranes 
For isolation of bacterial outer membranes, ORT was grown (48 h, 37°C, 5% CO2) onto Columbia 
agar (plates) and then in 200 ml of Todd-Hewitt broth (48 h, 37°C, in air) at 150 rpm. Bacteria were 
collected by centrifugation (4,000 x g, 15 min, 4°C) and resuspended in 10 mM of Tris-HCl, pH 7.4. 
Bacterial outer membranes were essentially extracted as previously described (Pannekoek et al., 1992) 
with some modifications. Briefly, the bacteria were disrupted by sonication and the intact cells and 
insoluble debris were removed by centrifugation (12,000 x g, 5 min, 4°C). The supernatant was 
centrifuged (100,000 x g, 1 h, 4oC) to pellet the bacterial membranes. Outer membranes were isolated 
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after solubilization of the inner membrane in 10 mM of Tris-HCl (pH 7.4) containing 2% sodium N-
lauroyl sarcosinate (1 h, 37oC). The outer membranes were collected by centrifugation (100,000 x g, 1 
h, 4oC), resuspended in 10 mM of Tris-HCl and stored at –20°C awaiting further analysis.  
 
Purification of lipopolysaccharide (LPS) 
LPS was extracted and purified by hot phenol extraction according to Johnson and Perry (1976) 
with minor modifications. In brief, ORT was grown (37°C, 48 h, 150 rpm in air) in two liters of Todd-
Hewitt broth and collected by centrifugation (7,000 x g, 20 min, 4°C). The bacteria were resuspended 
in 10 times of wet weight of distilled water and an equal volume of hot phenol (70°C) (Merck, 
Darmstadt, Germany) was added. The mixture was incubated (2 h, 70°C) in a water bath and vortexed 
for 1 min at 15 min intervals. After cooling on ice, the mixture was centrifuged (18,000 x g, 20 min, 
4°C) and the waterphase (supernatant) was collected. Then, two volumes of acetone (-20°C) and  100 
mg per gram bacterial wet weight of sodium-acetate were added to the waterphase. The mixture was 
centrifuged again, the pellet (with the LPS) washed in acetone (-20°C), again collected by 
centrifugation, and resuspended in distilled water. This solution was centrifuged (100,000 x g, 2 h, 
4°C) to remove contaminating DNA. The pellet with the LPS was resuspended in distilled water and 
stored at -20°C until use. This procedure yielded 40 and 20 mg of pure LPS from two liters of ORT 30 
and 41 cultures, respectively. The purity of the LPS was verified by SDS-PAGE and silver staining 
(Tsai and Frasch, 1982). 
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Tricine SDS-
PAGE 
Bacterial outer membrane protein analysis was performed using SDS-PAGE as described 
(Laemmli, 1970) using 4% (w/v) stacking gel and 10% (w/v) separating gels. Electrophoresis was 
performed at a constant voltage (100 V) in the Protean II electrophoresis cell (BioRad Laboratories, 
Richmond, CA). Separated proteins were visualized with 0.25% Coomassie Brilliant Blue R-250. 
Bacterial LPS was characterized using 16.5% tricine SDS-PAGE essentially as described (Schagger 
and von Jagow, 1987). LPS was visualized by silver staining according to the method of Tsai and 
Frasch (1982).  
 
 
RESULTS 
Kinetics of ORT adherence  
The ability of ORT to adhere to eukaryotic cells was assessed by incubating cultured Chang 
epithelial cells in the presence of ORT strain 30 for various periods of time. Microscopic evaluation of 
infected epithelial cells indicated that strain 30 efficiently adhered to the cells in a time-dependent 
fashion with up to 40 adherent bacteria per cell at 6 h of infection (Fig. 1A). Microscopy showed 
bacteria apparently randomly distributed over the cell surface and that most of the cultured cells 
carried bacteria at their surface (Fig. 1B). No signs of cell toxicity were noted during the six-hour 
infection period. At prolonged infection (24 h), most epithelial cells had detached from the coverslips. 
This effect was not observed when cells were exposed to a 1/1 dilution of filtered (0.22 µm) culture 
supernatants collected from 24 h of infected cells, suggesting that the effect was probably not caused 
by a secreted toxin. 
Further characterization of the bacterial adhesion showed that when different bacterial inocula 
(5x106-5x109) were applied to the cells, maximal adherence (approximately 100 bacteria per cell) was 
observed with an inoculum of 5x109. At this inoculum about 10% of the added bacteria adhered to the 
cells. When 5 x 107 ORT was used as an inoculum, about 50% of the added bacteria adhered to the 
cells (Fig. 1C). These data indicate that the adherence event is a highly efficient and saturable process.  
Variation in the composition of the culture media yielded similar bacteria adherence for 
experiments were performed in RMPI 1640 or DMEM tissue culture medium, while strongly reduced 
adherence was observed when experiments were performed in Dulbecco's phosphate- or HEPES-
buffered salt solutions or with bacteria derived from solid phase media and liquid media (Fig. 1D). 
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This suggests that bacterial growth and/or specific components of the tissue culture media are required 
for ORT adhesion.    
Immunogold-silver staining of the infected specimen that enables discrimination of extracellular 
and intracellular bacteria, revealed a few intracellular ORT at 3 h of infection (data not shown), 
suggesting that, at least under the conditions employed, ORT is not very efficient in gaining access to 
the host cell interior. 
 
Time (h)
B
Plate      Broth
100

















20
40
60
Dose
5.106
C
5.107 5.108 5.109











80
100
A
dh
er
en
ce
 (O
R
T/
ce
ll)













20
40
60
2 4 6
A
A
dh
er
en
ce
 (O
R
T/
ce
ll)
50
30
10





















HBSS DMEM RPMI RPMI







20
40
60
D
80
A
dh
er
en
ce
 (O
R
T/
ce
ll)
 
Fig. 1: Kinetics and characteristics of ORT adherence to epithelial cells. 
(A) Time course of ORT adherence. Cultured Chang epithelial cells were incubated with plate-grown ORT strain 
30 for 2, 4 and 6 h at 37oC. Adherence was scored by microscopy and presented as the number of ORT per cell. 
Data are the mean ± SEM of three experiments. (B) Adherence of ORT strain 30 as viewed by fluorescence 
microscopy at 1000x magnification. (C) Effect of inoculum size on ORT adherence. Chang cells were infected 
with the indicated numbers of ORT strain 30. Infection was stopped at 3 h of infection. Data represent the 
average number (± SEM) of adherent bacteria per cell of three experiments. (D) Effect of type of incubation 
medium on ORT adherence. ORT strain 30 grown onto Columbia agar plates for 48 h was added to Chang 
epithelial cells maintained in HEPES-buffered salt solution (HBSS), DMEM or RPMI without serum. As a 
comparison, Todd-Hewitt broth grown ORT strain 30 was added to epithelial cells maintained in RPMI. At 3 
hours of incubation, infection was stopped and the number of cell-associated bacteria was determined. Data are 
the mean ± SEM of three experiments. 
 
Inter-strain variability and cell type specificity of ORT adhesion 
In order to ascertain that the adherence properties observed for ORT strain 30 (serotype D) 
represented a general feature of ORT strains, a number of other strains (grown on Columbia agar 
plates) was assessed for their ability to adhere to the cultured INT-407 epithelial cells. Strain 30 
adhered to these cells as efficient as to Chang cells (Fig. 2). Infection of the cells with strain 29 
(serotype D) and strain 7 (serotype A) also resulted in strong bacterial adherence when an inoculum of 
5 x 107 was applied (Fig. 2). Similar experiments with strain 41 (serotype E) consistently yielded only 
0-3 bacteria per cell under identical conditions (Fig. 2). 
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To further determine the cell type specificity of ORT adherence, adhesion of solid phase grown 
strains 29, 30 and 41 towards chicken red blood cells was assessed. The binding of ORT to red blood 
cells was explored in a haemagglutination assay with living and glutaraldehyde-fixed chicken 
erythrocytes. Incubation of the erythrocytes with various concentrations of ORT strains 29 and 30 gave 
virtually no haemagglutination. Similar experiments with  strain 41 yielded strong haemagglutination 
of both the unfixed and glutaraldehyde-fixed erythrocytes derived from different animals (Fig. 3).  
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Fig. 2: Inter-strain variability in ORT adherence. 
ORT strains 7, 29, 30 and 41 were added to cultured INT407 epithelial cells. Bacterial adherence (i.e. the average 
number of ORT per cell) was determined at 2 h (open bars), 4 h (light grey bars) and 6 h (dark grey bars) of 
infection. Results are the mean ± SEM of three independent experiments. 
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Fig. 3: Haemagglutination properties of ORT.  
(A) Chicken red bloods cells (RBC) were mixed with serial dilutions of agar plate-grown ORT strains 29, 30 and 
41 as indicated. After for 2 h of incubation (20oC), haemagglutination (HA) was scored. Note that ORT strain 41 
showed strong HA activity in contrast to strains 29 and 30. (B) Comparison of HA activity of solid phase- and 
broth-derived ORT strain 41. The assay was carried as described under (A). Note the reduction in HA activity 
from broth cultures compared to solid-phase grown bacteria. 
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Growth-medium dependent switching between red blood cell and epithelial cell ORT adhesive 
phenotypes 
The apparent cell type specificity of the strains 29 and 30 compared to strain 41 was further 
explored by direct comparison of the adherence of solid phase-grown and Todd-Hewitt broth grown 
bacteria to epithelial and red blood cells. When grown on Columbia (or Todd-Hewitt) agar plates prior 
to the infection assay, ORT strain 41 that only poorly adhered to the epithelial cells, effectively 
agglutinated chicken red blood cells (Fig. 3). Conversely, when grown in Todd-Hewitt broth prior to 
infection, strain 41 lost the ability to haemagglutinate the erythrocytes (Fig. 3), but gained the ability 
to adhere to the epithelial cells. In fact, strain 41 adhered as efficient to the epithelial cells as strain 29 
and 30 with up to 55 bacteria per cell at 3 h of infection (Fig. 4). This switch was not observed when 
the bacteria were grown on Todd-Hewitt based agar plates (data not shown), suggesting that the 
transition in phenotype was caused by a change in growth phase rather than the composition of the 
medium. Together, these results strongly suggest that ORT strains carry different, cell type specific 
adhesins. 
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Fig. 4: Differential adherence of ORT strain 41. 
Chang epithelial cells were inoculated with ORT strains 30 (hatched bars) or 41 (solid bars) derived from solid-
phase (Plate) or liquid media (Broth). After 3 h of incubation, the infection was stopped. Data represent the 
average number of adherent ORT per cell. Note that the adherence properties of strain 41 but not of strain 30, 
varied with the growth media. 
 
Comparison of outer membrane profiles of ORT 
In order to investigate the difference in adherence properties of strain 41 compared to the other 
strains, we extracted outer membranes of the strains 29, 30 and 41 and compared their protein profiles 
by SDS-PAGE. As depicted in Fig. 5A virtually identical migration patterns were obtained for outer 
membrane proteins of strains 29 and 30. For strain 41 a different protein profile was observed 
particularly in the low molecular range (20-25 kDa).  
To examine the lipopolysaccharide (LPS) characteristics of the strains, LPS was purified from 
strain 29, 30 and 41 with the hot-phenol method. Analysis of the purified LPS with tricine SDS-PAGE 
revealed unique LPS profiles for all strains, including the serotype D strains 29 and 30. The size and 
migration of the LPS bands suggest that the LPS of ORT consists of a heterogeneous set of 
oligosaccharide molecules with a molecular mass between 3 and 10 kDa (Fig. 5B). The absence of a 
ladder-like migration of LPS bands in the higher molecular weight range suggests that, at least under 
the conditions employed, the assembly of the LPS molecules into a smooth from of LPS built up of 
large repetitive oligosaccharide units, does not occur in this species. 
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Fig. 5: Outer membrane profiles of different ORT strains. 
(A) - SDS-PAGE profile of outer membranes proteins (OMP) isolated from ORT strains 29, 30 and 41. Proteins 
are visualized with Coommassie Brillant Blue. (B) - Tricine-SDS-PAGE profile of LPS purified from ORT 
strains 29, 30 and 41 as visualized with silver staining. Note the heterogeneity in LPS bands among the ORT 
strains. 
 
Strain-specific and cell-type specific inhibition of ORT adherence by LPS 
In an attempt to relate observed differences in outer membrane composition with the different 
adherence properties of the ORT strains, we tested the effect of purified LPS on the ORT adherence to 
the cultured epithelial cells. Infection of Chang epithelial cells with the ORT strains 29 and 30 in the 
absence and presence of various concentrations (1-100 µg/ml) of endogenous purified LPS showed 
that the LPS of strain 29 inhibited bacterial adherence of strain 29 up to 90% (Fig. 6). A similar effect  
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Fig. 6: Strain specific inhibition of ORT adherence by LPS. 
Chang epithelial cells were infected with ORT strain 29 (solid bars) or strain 30 (hatched bars) in the absence and 
presence of the indicated amount of purified LPS derived from strain 29 (left panel) or strain 30 (right panel). 
Bacterial adherence was determined at 3 h of infection and indicated as average number of ORT per cell. Data 
are the mean ± SEM of three experiments. The inhibition of the bacterial adherence by LPS was statistically 
significant (P < 0.01) at concentrations ≥ 10 µg and ≥ 1 µg of LPS of strain 29 and 30, respectively. 
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was obtained for strain 30 when LPS of strain was added (Fig. 6). However, when heterologous LPS 
instead of homologous LPS was added to the infection assay, no inhibition of bacterial adherence was 
observed (Fig. 6). Thus, the LPS from strain 29 inhibited the adherence of strain 29 but not that of 
strain 30, while the LPS of strain 30 effectively blocked the adherence of strain 30 but not of strain 29. 
To further ascertain the observed cell-type specificity in ORT adherence, the effect of purified 
homologous and heterologous purified LPS on the haemagglutination facilitated by ORT strain 41 was 
investigated. No haemagglutination inhibitory effect of the purified LPS was observed (not shown). 
These data strengthen the concept that the observed inhibition of the ORT adherence by LPS is a 
specific event and  that ORT adherence to different cell types is conferred by strain-specific adhesins 
and/or host cell receptors.  
 
 
DISCUSSION 
 
Development of novel infection intervention and prevention strategies for the bacterial pathogen 
O. rhinotracheale requires more knowledge of the critical steps in the establishment of infection. Here 
we characterized the initial steps of the bacteria-host interaction, notably the adherence of ORT to 
eukaryotic cells. Our data indicate that ORT exhibits adhesive properties towards several types of 
epithelial cells as well as erythrocytes. The kinetics of the bacterial adhesion and the observed 
differential adhesion of different ORT strains to epithelial cells and erythrocytes, indicate that the 
binding is a specific and conferred by cell type-specific adhesions. The remarkable ORT strain-specific 
inhibition of the bacterial adhesion by purified LPS indicates that bacterial and/or host LPS receptors 
play a crucial role in the establishment of cellular ORT infection. 
The first indication that ORT exhibits adhesive properties was obtained from the tight attachment 
of the bacteria to the epithelial cells in our in vitro infection model system. The time course, 
specificity and saturability of the adhesion process suggested that the binding was a specific event. 
This was further strengthened by the apparent lack of adhesion of strain 41 under conditions that 
allowed strains 7, 29 and 30 to strongly adhere to the host cells.  The reason for the poor adherence of 
strain 41 is unknown but merits further investigation. Strain 41 acquired the ability to adhere to the 
epithelial cells when grown in Todd-Hewitt liquid medium instead of on Todd Hewitt-based agar 
plates despite its apparent normal growth on the agar plates compared to the adherent strains. The 
change in phenotype suggests that the strain has the intrinsic ability to adhere to epithelial cells but 
that this capacity is apparently influenced by the environmental conditions. It is currently unclear 
whether the transition of the strain from agar plates to liquid medium (and thus from a non-adherent to 
adherent phenotype) is accompanied by an unmasking of surface adhesins e.g. by a loss of a possible 
capsule or other  surface molecules, or by altered expression of surface adhesins. A switching between 
adherent and non-adherent phenotypes however, has been observed before and is to be considered of 
major importance for other pathogens as it may enable bacteria to both adhere and spread to other 
niches with changing  environmental conditions (Hertzig et al., 2003).   
Strong evidence for the existence of different cell-type specific adhesins on ORT was obtained 
from comparison of the ORT adherence to epithelial cells and erythrocytes. The apparent absence of 
(surface) haemagglutinins in strain 29 and 30 but their efficient adherence to epithelial cells clearly 
indicates the bacterial adhesins are host cell specific. Furthermore, the efficient haemagglutination of 
chicken erythrocytes by a phenotype of strain 41 that showed poor adherence to epithelial cells 
indicates the existence of multiple adhesins with different host cell specificity. Characterization of the 
outer membrane protein profiles of the strains 29, 30 and 41 revealed several differences between 
strain 41 and the strain 29 and 30. Whether these differences contribute to the different adherence 
properties of the strains remains to be investigated and awaits establishment of a system to genetically 
manipulate ORT. A similar point that remains to be addressed is the host specificity of the adhesins. 
While the haemagglutination assays were carried out with chicken erythrocytes, epithelial cell 
adherence was determined with a human epithelial cell infection model system. Thus, it is possible 
that additional avian specific adhesins will be identified when a suitable chicken epithelium model 
system has been established.  
A striking finding from our work was the apparent heterogeneity in LPS molecules produced by 
the different strains. With the presence of relatively small molecular mass of the LPS molecules 
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(between 3 and 10 kDa) and the finding that a single strain appeared to produce multiple LPS 
molecules, the LPS of ORT mimics that of many other mucosal non-intestinal pathogens such as 
Haemophilus influenzae and Neisseria species. In these species, multiple lipooligosaccharides (LOS) 
molecules are produced simultaneously often reflecting natural variation in LOS biosynthesis (van 
Putten and Robertson, 1995). Whether the LPS of ORT is subject to variation is unknown and awaits 
the development of specific antibodies. The dissimilarity of LPS bands of strains 29 and 30 which 
both belong to ORT serotype D, suggests that the serotype classification of ORT strains is probably not 
based on differences in  LPS.   
The apparent unique LPS profile of the different ORT strains tested is consistent with observed 
apparent LPS sensitivity of the ORT adhesion to epithelial cells.  In our infection experiments, purified 
LPS inhibited bacterial adhesion in a strain-specific fashion i.e. infection inhibition was only observed 
for the strain from which the LPS was purified. The finding that the adherence of strain 29 to the host 
cells was inhibited by LPS of strain 29 but not of strain 30, while the adherence of strain 30 was 
blocked by the LPS of strain 30 but not of strains 29 or 41 indicates that the inhibition was unlikely 
caused by impurity of the LPS. On the contrary, the data point to LPS-type specific mechanism of 
interaction between ORT and the host cells. At this point it would be of interest to investigate the 
repertoire of LPS molecules produced by ORT to gain more information about the extent of variation 
in bacterium-host cell interactions that has evolved in this species. 
The mechanism via which LPS exerts its strain-specific infection inhibitory effect remains to be 
resolved. The data suggest that LPS-specific receptors on the bacteria and/or host cell are involved in 
the adherence process.  It can be imagined that LPS acts as a receptor analog that binds to the bacterial 
adhesin thus preventing it to bind to the host cell receptors. In this scenario, the host cell receptors 
recognized by ORT should exhibit LPS mimicry. Candidate receptors with such properties would be 
host cell glycolipids. Host cell gangliosides have been implicated as receptors for other bacterial 
pathogens (Bitzan et al., 1998). Whether LPS of ORT exhibits mimicry with host cell glycolipids 
awaits structural analysis of the molecule.  An alternative explanation for the LPS inhibition of ORT 
infection is that the purified LPS inhibits bacterial adherence by acting as an analog of the ORT 
adhesin and thus occupies host cell receptors that are otherwise exploited by the bacterium. In this 
case, LPS itself would likely be the bacterial adhesion conferring molecule. Further analysis of the 
molecular basis and biological activity of the inhibitory effect may provide insight into the potential 
value of (parts of) this molecule in future infection intervention and/or prevention. 
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ABSTRACT 
 
The emerging bacterial pathogen Ornithobacterium rhinotracheale (ORT) causes respiratory 
infections in birds and is a major problem in the poultry industry. Pathology suggests that the bacteria 
infect macrophages and elicit an inflammatory response. To better understand the ORT-macrophage 
interaction, we infected HD-11 chicken macrophages with ORT strain 30. Microscopy showed a dose-
dependent, non-opsonic adherence and uptake of ORT by the macrophages. Measurement of nitric 
oxide production as an inflammatory marker demonstrated that viable ORT stimulated NO production 
albeit much less than E. coli or S. Enteritidis. Priming of the macrophages with recombinant chicken 
gamma-interferon (rChIFNγ) slightly enhanced the NO production. The lipid A neutralizing agent 
polymyxin B did not inhibit NO production stimulated by ORT. This compound did effectively block 
the stimulation by the enteric bacteria. Addition of LPS purified from ORT to the HD-11 cells 
stimulated NO production in rChIFNγ primed HD-11 cells in a polymyxin B-sensitive fashion, 
suggesting that, in purified form, LPS of ORT exhibits pro-inflammatory activity. Infection 
experiments with rMoIFNγ stimulated murine macrophages (J774A.1 cells) showed that both viable 
ORT and purified LPS did not stimulate NO production. Together, the results indicate that ORT is 
rapidly ingested by macrophages and elicits an inflammatory response in chicken macrophages via a 
stimulus other than LPS. LPS of ORT is only bioactive in purified form. The observed differential 
responsiveness of chicken and mouse cells may contribute to the host specificity of the infection. 
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INTRODUCTION 
 
In recent years, the Gram-negative bacterium Ornithobacterium rhinotracheale (ORT) has 
emerged as an important bacterial pathogen in turkeys and chickens (Sprenger et al., 2000a; 2000b; 
van Veen et al., 2000). Contact with this bacterium often results in clinical signs varying from mild 
symptoms of respiratory tract infection to systemic disease with arthritis, growth retardation and 
considerable mortality (van Empel and Hafez, 1999; van Veen et al., 2000). Pathological examination 
of infected tissues at 2 days of ORT exposure showed infiltration of the respiratory epithelial mucosa 
with macrophages and polymononuclear leukocytes. At a later stage, granulomatous tissue was 
observed and a further accumulation of macrophages was seen at the site of infection (DeRosa et al., 
1996: van Empel et al., 1999). The inflammatory response and the predominant association of ORT 
with macrophages (van Empel et al., 1999) suggest that this cell type plays a pivotal role in the 
pathogenesis and/or outcome of ORT disease.   
 The molecular mechanisms via which ORT attracts and/or possibly evades killing by professional 
phagocytes have not been investigated. Chicken macrophages have been reported to be capable of 
killing both extra- and intracellular bacteria via production of nitric oxide (NO) (Karaca et al., 1995; 
Lin et al., 1996; Qureshi et al., 1994; Sung and Dietert, 1994; Taylor et al., 1992). This compound is a 
free radical generated from L-arginine by the inducible enzyme NO synthase (iNOS). NO is a potent 
inflammatory mediator that has anti-bacterial activity by generating highly reactive compounds via 
oxidation to nitrite and nitrate and by binding to bacterial metallo-enzymes (Lancaster, 1992; 
Moncade, 1991). Maximal iNOS expression typically requires the presence of specific combinations 
of lipopolysaccharide (LPS) and/or cytokines (Dil and Qureshi, 2002; Geller et al., 1993; Kunz et al., 
1994; Lin et al., 1996; Tsujino et al., 1994; Weisz, 1994). Known stimuli that induce iNOS in chicken 
macrophages are various immunological stimuli such as LPS and IFNγ and tumor necrosis factor-α 
(Karaca et al., 1995; Lin et al., 1996; Qureshi et al., 1994; Sung and Dietert, 1994; Taylor et al., 
1992), although the response may vary with the genetic background of the chicken (Hussain and 
Qureshi, 1997; Kogut et al., 2001; Qureshi et al., 1994; Sekellick et al., 1998). Once induced, iNOS 
remains active for sustained periods and produces large amounts of NO. Whether ORT induces or 
inhibits the production and/or resists the toxic activity of NO has not been investigated. 
The present study was designed to unravel the cellular interaction between ORT and chicken 
macrophages. Using the chicken macrophage HD-11 cell line (Beug et al., 1979) as a model system, 
the bacterial adherence and ingestion of ORT by macrophages was investigated. The development of 
an inflammatory response was assessed using NO production as marker. Results with ORT were 
compared with those obtained for the enteric pathogens Escherichia coli (E. coli) and Salmonella 
enterica serovar Enteritidis (S. Enteritidis). The host specificity of the effects was evaluated by 
comparing the interaction of ORT with chicken and murine macrophages.  
 
 
MATERIALS AND METHODS 
 
Bacterial strains, media and growth conditions 
O. rhinotracheale strains 29, 30 and 41 were isolated from turkeys and kindly provided by Dr. P. 
van Empel (Intervet B.V., The Netherlands). Strains were grown on Columbia agar (Oxoid, 
Hampshire, England) at 37°C for 48 h in a humidified atmosphere of 5% CO2 in air or in 45 ml of 
Todd-Hewitt (TH) broth (Oxoid, Hampshire, England) in 50 ml polypropylene tubes at 37°C for 48 h 
in air on an orbital shaker (150 rpm), unless indicated otherwise. E. coli strain DH5α and S. enterica 
serovar Enteritidis (S. Enteritidis) strain 706 were grown on LB agar plates or in LB broth. 
 
Cell culture  
The chicken macrophage cell line HD-11, generated by transformation of chicken hematopoietic 
cells with myelocytomatosis virus (MC-29) (Beug et al., 1979), and the murine (Balb/C) macrophage 
cell line J774A.1 (ATCC TIB-67) (Ralph and Nakoinz, 1975) were grown in RPMI 1640 
supplemented with 5% fetal bovine serum. For use in infection experiments, cells were seeded onto 12 
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mm circular glass coverslips in 24-well tissue culture plates (Costar, New York, USA) and grown for 
48 h at 37°C in a humidified atmosphere of 5% CO2 in air. 
 
Infection experiments 
Cellular infection was started by adding various numbers (5x106 - 5x109) of bacteria suspended in 
Dulbecco's phosphate buffered saline (DPBS) to cultured macrophages (≈105 cells/well) maintained in 
1 ml of serum-free RPMI. After various times of incubation (37°C, 5% CO2), the infection was 
stopped by rinsing the cells three times with 1 ml of DPBS followed by fixation in 1 ml of 2% 
paraformaldehyde in DPBS for at least 1 h. The cells were stained with 0.002% crystal violet and 
viewed in an Olympus BH-2 microscope. At least 30 cells per well were randomly viewed to estimate 
the number of bacteria associated with the eukaryotic cells. Data are expressed as the mean ± SEM of 
at least three representative experiments. Statistical analysis was performed with the independent 
Student’s t-test using SPSS 9.0 software. 
 
Purification of lipopolysaccharide (LPS) 
LPS was extracted and purified according to the hot phenol extraction procedure of Johnson and 
Perry (1976) with minor modifications. In brief, 2 liter cultures of bacteria grown (37°C, 150 rpm) in 
Todd-Hewitt broth in Erlenmeyer flasks for 48 h, were collected by centrifugation (Avanti J-20xp 
centrifuge, Beckman Coulter, USA) (6,800 x g, 20 min, 4°C). The bacterial yield was determined by 
weighing of the pellets. The bacteria were then resuspended in a volume of 10 times of bacterial wet 
weight of distilled water and an equal volume of hot phenol (70°C) was added. The mixture was 
incubated at 70°C in waterbath for 2 h with regular vortexing, cooled to 4°C, and centrifuged (18,000 
x g, 20 min, 4°C). The waterphase (supernatant) was collected and two volumes of acetone (-20°C) 
plus 100 mg of sodium acetate per gram of bacterial wet weight were added. After another 
centrifugation step (18,000 x g, 30 min, -20°C), the pellet was washed in aceton (-20°C) and 
centrifuged again. Then the pellet was resuspended in distilled water and centrifuged at 100,000 x g 
(TL-100 Ultra centrifuge, Beckman) for 2 h at 4°C to remove DNA contamination. The pellet (i.e. the 
purified LPS) was dissolved in distilled water and stored at –20°C until use. The purity of the LPS was 
verified by SDS-PAGE and silverstaining (Tsai and Frasch, 1982). In the infection experiments, LPS 
from Ornithobacterium rhinotrachele (LPS-ORT), Salmonella Enteritidis (LPS-SE) or Escherichia 
coli (LPS-EC) was used at a concentration of 1 µg/ml, unless indicated otherwise. 
 
Nitric oxide assay 
Nitric oxide (NO) production in culture supernatants of infected macrophages was measured with 
the Griess assay (Green et al., 1982). Supernatants were collected from cells grown in RPMI plus 5% 
FBS that had been incubated in the same medium with different concentrations of bacteria or purified 
LPS for various periods as indicated in results. In some experiments, 100 ng/ml of recombinant 
chicken gamma-interferon (rChIFN-γ, generally provided by Dr. E. Tijhaar, Utrecht University, The 
Netherlands) or 400 IU/ml recombinant mouse gamma-interferon (rMoIFNγ, BD Biosciences, 
Belgium) were added at 2 h before the addition of the bacteria or LPS. When appropriate, the lipid A 
neutralizing agent polymyxin B (PB, 20 or 60 µg/ml, Sigma) was added. The concentration of NO was 
determined by mixing 250 µl of culture supernatant (or dilutions of it) with an equal volume of freshly 
prepared Griess reagent (1% sulfanilamide, 0.1% naphthylethylene diamine in 2.5% phosphoric acid). 
After 10 min of incubation at 20°C, use of substrate was measured in a spectrophotometer at 550 nm. 
The concentration of nitrite in the medium was calculated from a standard curve generated by mixing 
0 to 100 µM of sodium nitrite with Griess reagent. All experiments were done in triplicate. Data are 
presented as the mean ± SEM of at least three experiments and statistically analyzed with the 
independent Student’s t-test with SPSS 9.0 software. 
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RESULTS 
 
Adherence and uptake of ORT by chicken macrophages 
The primary interaction between ORT and chicken macrophages was studied using the HD-11 
cell line as a model system. Infection of HD-11 cells with ORT strains 29 and 30 (serotype D) for 
various periods showed that ORT adhered to and was ingested by the phagocytic cells. Microscopy on 
the infected specimen revealed about 50 cell-associated bacteria at 3 h of infection. These bacteria 
seemed to be located in large vacuoles inside the cells (Fig. 1A). Comparison of the effect of the 
inoculum size on the interaction indicated that the bacterial adherence and uptake steadily increased 
from 6 to 70 bacteria per cell with inoculum sizes of 5x106 and 5x109, respectively (Fig. 1B).  
Infection experiments with ORT strain 41 (serotype E) yielded similar results but only when the 
inoculum was prepared from bacteria grown in Todd-Hewitt broth prior to infection. ORT strain 41 
grown on solid phase media adhered much less to the HD-11 cells (p<0.05, Fig. 1C). 
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Fig. 1: Kinetics and characteristics of ORT adherence to macrophages. 
(A) Micrograph of ORT infected macrophages (1000x magnification). Note the intracellular vacuoles containing 
ORT. (B) Effect of inoculum size on ORT adherence to macrophages. Chicken HD-11 macrophages (hatched 
bars) and murine J774A.1 macrophages (solid bars) were infected with the indicated doses of ORT strain 30. 
Infection was stopped at 3 h of infection. Data represent the average number (± SEM) of adherent ORT per cell 
of three experiments. (C) Effect of bacterial growth media on the ORT-macrophage interaction. HD-11 
macrophages were infected with ORT strains 30 and 41 derived from solid phase (Plate) and liquid media 
(Broth). After 3 h of incubation, the infection was stopped and the average number of ORT per macrophage was 
determined. Data are the mean ± SEM of three experiments. 
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Inhibition of ORT infection of macrophages by LPS 
The adhesion characteristics of the various ORT strains towards the HD-11 cells closely 
resembled those previously reported for the ORT-epithelial cell interaction (Chapter 2). In order to 
assess whether the adhesion to both cell type was conferred by the same mechanism, the effect of LPS 
on the cellular infection was tested as this molecule inhibits the ORT adhesion to epithelial cells in a 
strain-specific fashion. Infection assays with HD-11 cells and ORT strain 30 in the absence and 
presence of purified LPS derived from this strain or from strain 29 yielded no inhibition of adhesion 
(Fig. 2). Similar results were obtained for strain 29 (data not shown). These results strongly suggest 
that the ORT adhesion to macrophages and epithelial cells proceeds via different mechanisms. 
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Fig. 2: Effect of purified LPS on the ORT adherence to macrophages. 
HD-11 macrophages were infected with ORT strain 29 (solid bars) or strain 30 (hatched bars) in the absence and 
presence of the indicated amounts of purified LPS derived from strain 30. Bacterial adherence was determined at 
3 h of infection and indicated as the average number of ORT per cell. Data are the mean ± SEM of three 
experiments. Note that purified LPS did not inhibit the ORT adherence. 
 
Stimulation of NO production by ORT 
Interaction of macrophages with bacterial pathogens often results in activation of the host defense 
including the production of the bactericidal molecule nitric oxide. To investigate the response of the 
HD-11 cells to ORT infection, the concentration of NO in the tissue culture supernatants was measured 
during a 24 h infection period. As shown in Fig. 3, ORT infection stimulated NO production. The 
concentration of NO steadily increased during the 24 h of infection and reached on average a 
concentration of 70.3 µM and 81.0 µM of NO per 105 cells for strains 30 and 41, respectively. 
Maximal NO levels were already obtained when 5x105 bacteria were used as an inoculum. Similar 
results were obtained for strain 29 (data not shown). With inocula of 5 x 107 cfu/ml, a poor response 
was measured for strains 29 and 30, probably because of the detachment of cells that occurred at 
prolonged infection at this high inoculum. Infection with strain 41 did not cause cell damage and 
yielded high levels of NO production even after 24 h of infection with 5x107 cfu/ml (Fig. 3).  
As the production of the enzyme nitric oxide synthase (iNOS) is enhanced in the presence of 
gamma-interferon (IFNγ), we also measured NO production in HD-11 cells primed with recombinant 
chicken IFNγ (rChIFNγ, 100 ng/ml). Priming with rChIFNγ enhanced the ORT induced NO 
production by about 50-90% for all ORT strains tested (Fig. 4A). The specificity of the effect was 
demonstrated by the ineffectiveness of recombinant murine IFNγ (rMoIFNγ, 400 IU/ml) to enhance 
the NO response (data not shown). 
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Fig. 3: Kinetics and characteristics of ORT-induced nitric oxide production. 
HD-11 macrophages were infected with various amounts of ORT strain 30 (left panel) and strain 41 (right panel). 
After 4, 8, 12 and 24 hours of incubation, the infection was stopped and the number of macrophage-associated 
bacteria was determined. Data represent the mean number of ORT per cell. Inocula used were: 5 x 105 (grey 
bars), 5x106 (hatched bars) and 5x107 (solid bars). The amount of NO detected in the supernatant of uninfected 
cells served as control (open bars). Results are the mean ± SEM of three independent experiments. 
 
Comparison of NO production induced by ORT, E. coli and S. Enteritidis in resting and IFNγ 
activated HD-11 cells 
In order to be able to interpret the significance of the ORT-induced NO production in HD-11 
cells, we compared the effect with that of the enteric bacteria E. coli and S. Enteritidis. Infection of 
HD-11 cells with these bacteria caused much more rapid NO production compared to ORT (Fig. 4B). 
For E. coli, NO was already detected at one h of infection, while at 2 h an average concentration of 80 
µM of NO was measured in the medium. For S. Enteritidis a slightly delayed response was measured 
of 60 µM of NO at 3 h of infection (Fig. 4B). At this time, ORT did not induce a detectable response 
yet (Fig. 4A). When the infection experiments and NO assays were repeated after priming of the HD-
11 cells with rChIFNγ, similar NO concentrations were measured in supernatants of E. coli and S. 
Enteritidis as for the absence of the cytokine (Fig. 4B), indicating that the NO response induced by 
these species is not enhanced by rChIFNγ in contrast to the response to ORT (Fig. 4). 
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Fig. 4: Effect of IFNγ on bacteria-induced NO production. 
(A) HD-11 cells were infected with 5x106 cfu/ml of ORT strains 29 and 41 and (B) E. coli and S. Enteritidis, in 
the absence (open bars) and presence (solid bars) of rChIFNγ. Infection was stopped at the indicated times and 
the concentration of NO present in the culture supernatants was determined. Data represent the mean 
concentrations ±SEM of three independent experiments. Note the difference in kinetics and IFN dependence of 
the NO production induced by ORT strains (Panel A) and the other species (Panel B).  
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Inhibition of E. coli and S. Enteritidis but not ORT induced NO production by polymyxin B 
One of the primary stimuli of Gram-negative bacterial pathogens that trigger the host defense is 
lipopolysaccharide (LPS). In search for the nature of the bacterial stimulus that stimulated NO 
production, we tested the inhibitory effect of polymyxin B on the ORT, E. coli and S. Enteritidis 
induced NO production in HD-11 cells. Polymyxin B has been demonstrated to inhibit the biological 
activity of LPS through binding to the lipid A moiety of the molecule (Lasfargues et al., 1989). 
Addition of polymyxin B to the HD-11 cells prior to infection completely prevented the induction of 
NO production by both E. coli and S. Enteritidis during the first 3 h of infection (Fig. 5A). In contrast, 
no inhibitory effect of polymyxin B on the ORT stimulation of NO production was observed (Fig. 5B). 
These results suggest that E. coli and S. Enteritidis stimulate NO production mainly via their LPS, 
while the ORT response is induced by a different stimulus.   
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Fig. 5: Inter-species variability of the induced NO production by polymyxin B. 
HD-11 cells were infected with (A) E. coli (5x106 cfu/ml) and (B) ORT strain 30  (5x106 cfu/ml) in the absence 
(open bars) and presence of rChIFNγ (hatched bars), polymyxin B (grey bars), or rChIFNγ plus polymyxin B 
(solid bars). At the indicated times, the infection was stopped and the concentrations of NO in the culture 
supernatants were determined. Values are the mean ± SEM of three assays. Note that NO production induced by 
the enteric bacteria is not enhanced by rChIFNγ but is blocked by polymyxin B, while the NO production 
induced by ORT is enhanced by rChIFNγ and not polymyxin B-sensitive. 
 
Comparison of the bioactivity of purified LPS of ORT, E. coli and S. Enteritidis 
To further investigate the apparent LPS-based difference in responsiveness of HD-11 cells 
towards the enteric bacteria and ORT, we tested the effect of purified LPS of these bacteria for its 
ability to stimulate NO production. For this purpose, LPS was purified by the hot-phenol method 
(Johnson and Perry, 1976). Addition of purified LPS of E. coli to the HD-11 cells elicited a strong NO 
response after 16 h of exposure, but only when the cells had been primed with rChIFNγ (Fig. 6). The 
response was prevented in the presence of polymyxin B demonstrating that it was mediated by lipid A 
(Fig. 6). For S. Enteritidis LPS, similar results were obtained, although in this case a moderate 
response was already observed in the absence of rChIFNγ (Fig. 6). Remarkably, the purified LPS 
derived from ORT strain 30 also stimulated NO production. This response was enhanced with cells 
that has been primed with rChIFNγ and was largely prevented by the addition of polymyxin B (Fig. 6). 
Similar results were obtained with LPS derived from ORT strains 29 and 41. These results suggest that 
LPS of ORT has the intrinsic ability to stimulate the NO response but is not biologically active in the 
context of the intact bacterium.  
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Fig. 6: Differential stimulation of NO production by LPS of different species. 
LPS purified from ORT strain 30, E. coli and S. Enteritidis was added to HD-11 cells in the absence (open bars) 
and presence of rChIFNγ (hatched bars) or rChIFNγ plus polymyxin B (solid bars). After 24 h of incubation was 
maximum NO production levels were achieved, concentrations of NO in the culture supernatants were 
determined. Data are the mean ± SEM of three experiments. Note that, once purified, the LPS of all species 
(including ORT) stimulates NO production in the presence of rChIFNγ in a polymyxin B-sensitive fashion. 
 
Differential effects of ORT and enteric pathogens on NO production in murine macrophages 
The above results indicate that ORT stimulates NO production in HD-11 cells via a different 
stimulus than LPS. To further investigate the host specificity of this event, we assessed the ability of 
ORT to stimulate NO production in murine macrophages. Infection of J774A.1 cultured murine 
macrophages cells with ORT strains 30 and 41 resulted in adherence to and uptake of the bacteria by 
the eukaryotic cells (Fig. 2). Moreover, the kinetics of infection and optimal inoculum size resembled 
those determined for the chicken HD-11 cells. Measurement of NO production showed that ORT strain 
30 did not induce any NO production during the 24 h infection period, irrespective of priming with 
400 IU/ml of rMoIFNγ (Fig. 7). Similar results were obtained for strain 29 and 41 (data not shown). 
On the other hand, E. coli and S. Enteritidis were able to stimulate NO production with similar kinetics 
as determined for HD-11 cells and in a polymyxin-sensitive fashion (Fig. 7). The absence of an ORT 
response in the murine macrophages may indicate that the stimulus that induces the NO production in 
this cell type is species-specific. 
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Fig. 7: Resistance of murine macrophages against ORT-stimulation of NO production. 
Murine J774A.1 macrophages were infected with ORT strain 30, E. coli and S. Enteritidis (5x106 cfu/ml) in the 
absence (open bars) and presence of rMoIFNγ (hatched bars), and rMoIFNγ plus polymyxin B (solid bars). At 
the indicated times, the concentrations of NO in the culture supernatants were determined. Values are the mean ± 
SEM of three experiments. Note that unresponsiveness of the murine macrophages towards ORT compared to E. 
coli and S. Enteritidis. 
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DISCUSSION 
 
Pathology studies suggest that macrophages play a dominant role in the establishment, pathology  
and/or persistence of ORT infections (van Empel et al., 1999). From the present in vitro study we 
conclude that ORT adheres to and becomes ingested by both chicken HD-11 and murine J774A.1 
macrophages. The bacterial components that contribute to the infection of macrophages remain to be 
defined, although they appear to be different than those conferring ORT adhesion to epithelial cells. In 
the chicken but not murine cells, the infection is accompanied by a stimulation of NO production via a 
rather slow LPS- and IFNγ-independent mechanism. In contrast, infection of the cells with E. coli and 
S. Enteritidis yields a much more rapid increase in NO production via an LPS-dependent mechanism. 
This stimulation was observed for both the chicken and murine macrophages. Comparison of the 
biological activities of LPS purified from ORT, E. coli and S. Enteritidis indicate that, in contrast to 
intact ORT, purified LPS of ORT is biological active and equally potent as E. coli and S. Enteritidis 
LPS. Overall, the data indicate that ORT infects chicken macrophages and stimulates NO production 
but via a different mechanism than E. coli and S. Enteritidis. 
The finding that ORT adheres to and is internalized by chicken macrophages is consistent with the 
tight association of the bacteria observed during in vivo infection (van Empel et al., 1999). Thus far, 
ORT has been isolated from domestic and wild birds suggesting that it has specificity for the avian 
host. Our data indicate that, at least under the conditions employed, ORT can infect murine 
macrophages. This suggests that if a host barrier exists for ORT and our data reflect the in vivo 
situation, this barrier is not located at the level of the macrophages. Alternatively, is can be imagined 
that ORT is able to colonize non-avian species but that this has not been noted because of the absence 
of associated pathology and/or unsuccessful isolation. The latter possibility is a serious option as our 
data suggest that ORT stimulates NO production in chicken cells only and isolation of ORT from 
colonized healthy animals is known to be difficult.  
The observed stimulation of NO production by ORT may contribute to the pathology observed 
during the natural infection. At first sight, the apparent specificity of the stimulation for chicken cells 
may appear not as a surprise as different types of macrophages have been reported to vary in 
sensitivity towards with regard to NO stimulation (Bermudez, 1993; Chesrown, 1994; Denis, 1994; 
Nathan and Hibbs, 1991; Schneemann et al., 1993; Yan et al., 1993). However, the finding that E. coli 
and S. Enteritidis but not ORT induced a potent NO response in the murine macrophage cell line 
suggest that the cause of the lack of response in this cell type is located in the bacteria rather than 
macrophages. The finding that bacteria can stimulate NO production in the absence of IFNγ has been 
previously reported (Crippen et al., 2003) and indicates that cytokine induction of  iNOS expression is 
not required for HD-11 cells. The increased response in the presence of rChIFNγ suggests that the cells 
still do respond to the cytokine and indicate that the effects of ORT on the host cells may vary with the 
presence of IFNγ at the site of infection. 
The observed apparent different kinetics and mechanisms of the stimulation of NO production by 
ORT, E. coli and S. Enteritidis point to the existence of fundamental differences between the Gram-
negative species. The differential polymyxin B sensitivity and increase in NO production observed for 
the various species indicate a different architecture and/or release of the LPS from the 
microorganisms. The ability of E. coli and S. Enteritidis to rapidly stimulate NO production via lipid A 
indicates that this molecule is presented in a biologically active form to the macrophages early in the 
infection. This does not hold for ORT as the NO response induced by ORT is not susceptible to 
inhibition by polymyxin B, suggesting that it is not mediated via lipid A. Further evidence that ORT 
exploits a different mechanism of macrophage activation is the apparent specificity of the effect for 
chicken macrophages which was not noted for E. coli and S. Enteritidis. The apparent absence of the 
LPS stimulus and the relative slow increase in NO production by ORT compared to E. coli and S. 
Enteritidis may at least partially explain why ORT seems to cause a comparatively moderate 
inflammatory reaction during the natural infection.  
The natures of the ORT stimuli that drive the stimulation of NO production remain to be 
determined. The stimuli appear to activate chicken but not murine macrophages and thus show host 
specificity. The finding that ORT stimulates NO production in a polymyxin B-insensitive fashion 
without prior priming of the macrophages with rChIFNγ but that this response is enhanced in 
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rChIFNγ-activated macrophages, suggests either the existence of multiple ORT stimuli or a higher 
sensitivity of the cells for a distinct stimulus after IFNγ exposure. In this regard, it may be noteworthy 
that ORT pathology is generally increased following priming of the animals with e.g. NDV virus. On 
the basis of our results, a scenario can now be envisioned in which this increased pathology is based 
on a virus-induced, IFNγ-mediated activation of the macrophages that renders the cells more 
susceptible to stimulation by ORT. This may result in a more profound inflammatory response and 
associated pathology.  
The structure of the LPS of ORT has thus far not been studied. We previously demonstrated that 
the LPS of ORT strains 29, 30 and 41 consist of a set of one of more oligosaccharides with molecular 
masses between 3 and 10 kDa when analyzed by tricine SDS-PAGE (Chansiripornchai and van 
Putten, unpublished results). The present data indicate no heterogeneity with regard to the  biological 
activity of the LPS purified from these strains. Comparison of the biological activities of the purified 
LPS as estimated by the ability to stimulate NO production, suggests that the lipid A moiety of the 
ORT LPS is equally potent as the purified LPS of E. coli and S. Enteritidis. The significance of these 
observations however, appears limited as our data indicate that the biological activity of purified LPS 
gives no indication as to the activity of the LPS in the context of the intact bacterium and the kinetics 
of the stimulation of the NO production for the intact bacteria and the purified LPS are quite different.  
Our data do indicate that the adhesion and bacterial uptake of ORT by the macrophages and the 
stimulation of NO production are separate phenomena as adherence was a rapid process without 
apparent host specificity, while NO production was detected much later and for in chicken 
macrophages only. A major future challenge is to identify the molecules involved in the interaction 
and  the fate of the internalized bacteria. The latter awaits development of suitable methods as  
classical bacterial survival assays based on selective killing of extra- and intracellular bacteria (e.g. the 
gentamicin survival assay) cannot be applied for ORT due to its wide-spread resistance to most 
common antibiotics (Devriese et al., 2001). 
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ABSTRACT 
 
The avian bacterial pathogen Ornithobacterium rhinotracheale (ORT) adheres to epithelial cells and 
macrophages and induces of an inflammatory response. The molecular basis of these interactions is 
not known. Here we report that serum has ORT infection-inhibitory activity. Both bovine and chicken 
serum inhibited ORT attachment to cultured epithelial cells in a dose-dependent fashion, while the 
interaction with chicken macrophages was unaffected. Chemical and size fractionation of serum 
revealed that the cell-type specific infection inhibitory activity was predominantly present in the 10 - 
100 kDa serum glycoprotein fraction and in the glycolipid fraction, suggesting that carbohydrates may 
exert the effect. Preincubation of ORT and host cells demonstrated that the infection-inhibition 
occurred via an effect on ORT rather than the host cells. Bindings assays with biotinylated isolated 
serum glycoproteins showed direct binding of several serum proteins to ORT. Comparison of serum 
and the previously identified LPS infection-inhibitory activity showed that the effect of serum was not 
strain specific in contrast to the effect of LPS. Differential inhibition by serum of ORT adherence to 
epithelial cells and red blood cells indicated the existence of cell-type specific ORT adhesins. The 
identified inhibitors are potentially powerful instruments to identify ORT adhesins and may have 
prophylactic potential. 
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INTRODUCTION 
 
The bacterium Ornithobacterium rhinotracheale (ORT) is an emerging Gram-negative bacterium 
associated with respiratory tract infections in domesticated poultry (Vandamme et al., 1994). The 
pathogen was likely introduced to poultry from wild bird populations. Once inhaled, ORT colonizes 
the respiratory tract and causes local infections that may disseminate to the joints and other body sites. 
The rapid spread of the infection and the associated loss of production cause major economic losses to 
the poultry industry. Several whole cell vaccines and a series of hygienic measures to control the 
pathogen have been developed but their efficacy is relatively poor. A logical approach to develop 
better vaccines or other forms of infection prevention is to try to identify the key players in the 
establishment of the infection as these may serve as suitable targets of novel infection prevention 
strategies. 
We previously demonstrated that ORT adheres to several cell types and provokes an 
inflammatory response as indicated by the production of nitric oxide. Bacterial adherence to epithelial 
cells appears to involve strain specific elements as purified LPS was able to inhibit bacterial adhesion 
of the homologous strain but not of heterologous ORT strains (Chapter 2). ORT also adheres to and is 
ingested by chicken and mouse macrophages. These events are not inhibited by purified LPS, 
suggesting the existence of different adhesins and/or host cell receptors. Further diversity in the 
interaction between ORT strains and macrophages was observed for the stimulation of the production 
of the inflammatory mediator nitric oxide (NO). ORT stimulates NO production in chicken but not 
mouse macrophages suggesting the involvement of species signaling pathways. The bacterial stimulus 
of nitric oxide production has not been identified yet, but does not seem to be lipopolysaccharide 
(LPS) that in most other pathogens has a potent pro-inflammatory activity (Chapter 3). 
In further unraveling of the molecular events underlying the ORT-host cell interaction, we tested 
the effect of variable environmental conditions on the establishment and course of in vitro ORT 
infection, including the effect of serum on the cellular infection. Serum has previously been 
demonstrated to contain a number of factors that may facilitate the establishment, alter the tissue 
tropism, or block the bacterial infection of eukaryotic cells (Duensing and van Putten, 1997; van  
Putten, 1993; van Putten et al., 1997). Here we report that serum effectively inhibits ORT infection of 
epithelial cells but not macrophages. Serum fractionation and binding assays showed that a 
carbohydrate present on serum glycoproteins and glycolipids likely causes the inhibition. The 
inhibition was not strain-specific indicating that the inhibitory molecule may have therapeutic 
potential. 
 
 
MATERIALS AND METHODS 
 
Bacterial strains, media and growth conditions 
O. rhinotracheale strains 29 and 30 (serotype D) and strain 41 (serotype E) were isolated from 
turkeys and generally provided by Dr. P. van Empel (Intervet B.V., The Netherlands). Bacteria were 
grown in Todd-Hewitt (TH) broth (Oxoid, Hampshire, England) or onto Columbia (CO) agar (Oxoid, 
Hampshire, England) for 48 h at 37°C in a humidified atmosphere of 5% CO2 in air.  
 
Cell culture 
Human Chang conjunctiva epithelial cells (ATCC CCL-20.2), INT 407 intestinal epithelial cells 
(ATCC CCL-6) and chicken HD-11 macrophages (Beug et al. 1979) were maintained in RPMI 1640 
(Invitrogen, Paisley, UK) supplemented with 5% fetal bovine serum (FBS) (Bodinco B.V., Alkmaar, 
The Netherlands) and grown at 37°C in a humidified atmosphere of 5% CO2 in air. For use in 
infection experiments, cells were grown onto circular (12 mm) glass coverslips placed into 24-well 
tissue culture plates in 1 ml of RPMI plus 5% FBS. Prior to infection, the medium was replaced by 1 
ml of serum-free RPMI 1640, unless indicated otherwise. 
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Infection assay 
Infections were started out by the addition of a suspension of 5x107 viable bacteria harvested 
from CO agar plates to ≈105 cultured epithelial cells in absence of presence of various concentrations 
of FBS, fractions thereof, chicken serum (ChS), or purified bacterial lipopolysaccharide (LPS). After 3 
h of incubation, the cells were rinsed three times with 1 ml of Dulbecco's PBS (DPBS) to remove for 
bacteria and the infection was stopped by fixing the cells in 1 ml of 2% paraformaldehyde in DPBS for 
at least 1 h. After staining of the cells with 0.002% (HD-11 cells) or 0.005% (epithelial cells) of 
crystal violet, bacterial interactions with the host cells were viewed in an Olympus BH-2 light 
microscope. Bacterial adherence was determined by counting the number of adherent bacteria on at 
least 30 randomly picked cells. Data are presented as the average + SEM of at least three experiments 
and were statistically analyzed with the independent Student’s t-test using SPSS 9.0 software. 
In some infection assays, the bacteria (1x108) or eukaryotic cells (≈105 cells per well) were 
preincubated in 1 ml of RPMI containing no or 20% of serum, isolated serum fractions, or LPS for 30 
min. Before start of the infection, the bacteria were collected by centrifugation and washed twice with 
DPBS to remove all free serum or LPS components and resuspended in 1 ml of RPMI. After 
preincubation of the host cells (30 min), they were rinsed three times with 1 ml of DPBS. Infection 
experiments with the preincubated bacteria or eukaryotic cells were carried out as described above.  
 
Extraction of glycoproteins and glycolipids from serum 
Serum glycoproteins and glycolipids were extracted from FBS as described (Varki, 2002) with 
minor modifications. Briefly, 300 µl of FBS was mixed with methanol and chloroform at the ratio of 
3:8:4. After 10 min of incubation on ice, the mixture was centrifuged (8,800 x g, 1 min, 4°C) and the 
supernatant was collected. The pellet was dissolved in 1 ml of 4:8:3 volumes of 
chloroform/methanol/water and the extraction procedure was repeated. The obtained supernatants 
from both rounds of extraction were pooled. The final pellet was extracted 3 times with 1:1 
chloroform/methanol, 2:1 chloroform/methanol and 100% ethanol, respectively. The supernatants 
from these extractions were pooled with that from 1 and 2. The final pellet representing the serum 
glycoprotein fraction, was resuspended in distilled water and stored in siliconized tubes (Sigma-
Aldrich, Steinheim,Germany) at -80 °C. The pooled supernatants were lyophilized and stored at –20 
°C until further use. Size fractionation of the isolated glycoprotein fraction was carried out with 
Centricon C-10 and C-100 filtration devices (Millipore, Bedford, MA, USA) according the 
instructions of the manufacturer. 
 
Biotinylation of serum glycoproteins 
Serum glycoproteins (SGP) were biotinylated by mixing 1 mg of  SGP with 2 mg of EZ-Sulfo-
NHS-LC-Biotin (Pierce, Illinois, USA) in 1 ml of PBS. After 30 min of incubation (20oC), 50 mM of 
Tris-HCl, pH 7.4 was added to quench the free aminogroups. The mixture was loaded onto a C-10 or 
C-100 Centricon filter devices to remove the free biotin. The biotinylation procedure was verified by 
SDS-PAGE and Western blotting using horseradish peroxidase (HRP) conjugated streptavidin (Sigma 
Chemical, St. Louis, USA) as a conjugate.  
  
Protein binding assay  
Binding of biotinylated serum glycoproteins to the bacteria was measured by incubating 5x107 
bacteria with 50 µg of biotinylated SGP in siliconized tubes. After 30 min the mixture was centrifuged 
(12,000 x g, 5 min, 20oC) and the pellet was washed several times to remove unbound glycoprotein. 
Then, the pellet with the bound SGPs was dissolved in laemmli solution (Laemmli, 1970), boiled, and 
analyzed by SDS-PAGE and Western blotting.  
 
SDS-PAGE and immunoblot analysis 
Proteins were separated by SDS-PAGE (8% gels) and transferred onto nitrocellulose as described 
(Laemmli, 1970). Nitrocellulose membranes were blocked with 2% bovine serum albumin (BSA) in 
PBS for 30 min and then incubated with streptavidine-HRP diluted (1/10,000) in PBS supplemented 
with 0.5% BSA for 45 min. The blot was washed three times for 15 min with PBS to remove unbound 
conjugated before incubating with SuperSignal substrate working solution  (Pierce, IL, USA) was 
added. Enzyme activity was monitored using Fuji medical X-ray film.  
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Haemagglutination assay 
Chicken erythrocytes were isolated from heparinized chicken blood. In the haemagglutination 
assay (Eaves et al., 1989) both viable and 1% glutaraldehyde fixed erythrocytes were used with 
essentially similar results. Agglutination of chicken red blood cells was assessed by mixing 50 µl of 
1% erythrocytes with an equal volume of serial dilutions of ORT suspension (5x107 – 3.1x106 bacteria 
per ml) in DPBS in 96-well microtiter plates. Haemagglutination was scored at 2 h and 24 h of 
incubation at 20oC. 
 
 
RESULTS 
 
Differential inhibition by serum of the interaction of ORT with epithelial cells and chicken 
macrophages 
Infection of cultured epithelial cells with ORT strain 30 in the absence and presence of increasing 
concentrations of fetal bovine serum for 3 h revealed a dose-dependent inhibition of the ORT 
adherence by serum (Fig. 1). Half-maximal inhibition was obtained with approximately 1% serum, 
while virtually complete inhibition was observed at 5%. Similar effects were observed for strain 29 
(Fig. 1).  
To assess whether the inhibitory effect was specific for non-avian sera and thus perhaps explain 
the host specificity of infection, the effect of ORT-antibody free chicken serum on ORT infection was 
tested. Chicken sera even slightly more effectively inhibited the adherence of ORT strain 30 to the 
epithelial cells in a dose-dependent fashion (Fig. 1).     
ORT has previously been demonstrated to adhere to and become ingested by chicken 
macrophages (Chapter 3). Analysis of the effect of serum on the interaction of ORT strain 30 with 
macrophages showed that this event was not affected by serum. Even in the presence of 10% serum, 
unaltered bacterial adherence was observed (Fig. 2). In contrast, serum inhibited epithelial cell 
adherence (both to Chang cells and INT-407 cells) for all ORT strains tested (Fig. 2). These data 
suggest that ORT interaction with epithelial cells and macrophages is mediated via different, cell type-
specific adhesins and/or host cell receptors.   
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Fig. 1: Sensitivity of ORT epithelial cell adherence to serum factors. 
Chang epithelial cell were infected with ORT strain 29 (diamonds) and 30 (circles) in the absence and presence 
of the indicated concentrations of fetal bovine serum (open symbols) or chicken serum (closed symbols). After 3 
h of incubation, the infection was stopped and the number of bacteria that adhered to the cells was determined. 
Adherence is expressed as the average number of adherent ORT per cell. Values are from a representative 
infection assay. 
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Fig. 2: Cell-type specificity of the infection-inhibitory effect of serum. 
ORT strains 7, 29, 30  were added to cultured Chang epithelial cells and HD-11 chicken macrophages in the 
absence (open bars) and presence (filled bars) of 10% FBS. At 3 h of infection, the cells were washed to remove 
non-adherent bacteria and the number of cell-associated ORT was determined. Adherence is expressed as the 
average number of bacteria per cell. Values represent the mean ± SEM of three experiments. Note the 
differential sensitivity of the ORT adherence to epithelial cells and macrophages for all strains. 
 
Serum blocks ORT adherence through an effect on the bacteria rather than the host cells 
To locate the site of action of the infection inhibitory activity in serum, infection experiments 
were performed with ORT strain 30 in which either the bacteria or host cells were preincubated with 
serum. Following 30 min of preincubation, the bacteria or cells were washed to remove the unbound 
serum factors and the infection was started. This procedure demonstrated that the inhibitory activity of 
serum was caused by an effect on the bacteria rather than on the host cells. Preincubation of bacteria 
reduced bacterial adherence by 40% (Fig. 3), while preincubation of the host cells resulted in similar 
levels of adherence as in the absence of serum. This effect was observed for the adhesive strain 29 and 
30 and thus did not exhibit strain specificity.  
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Fig. 3: Serum interferes with the functional properties of ORT. 
The site of action of FBS was determined by preincubating either the ORT strains 29 (solid bars) and 30 (hatched 
bars) or the epithelial cells (Host cells) with 15% FBS for 30 min prior to infection. At 3 h of infection in the 
absence of serum, bacterial adherence was determined. Bacteria and cells not pre-incubated with serum served as 
control. Adherence is expressed as the average number of bacteria per cell. Data are the mean ± SEM of three 
experiments. Note that preincubation with serum of the bacteria but not the host cells, resulted in reduced 
adherence. 
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Characterization of the infection inhibiting factor in serum 
The nature of the factor(s) in serum that blocked the ORT infection of epithelial cells was further 
investigated by testing the inhibitory activity of distinct serum fractions. For this purpose, glycoprotein 
and glycolipid fractions were isolated from bovine serum and tested for their effect on ORT infection. 
As shown in Fig. 4A, both the glycoprotein and glycolipid fractions of serum effectively inhibited 
ORT epithelial cell adherence. Maximal inhibition was observed at a concentration of 1 µg/ml for  
SGP and SGL for both strains 29 and 30. Again, the interaction of ORT with macrophages was not 
affected by the presence of the isolated serum fractions (Fig. 4B). Size fractionation of the serum 
glycoprotein fractions using filters with various pore size and use of the obtained fractions in infection 
assays, indicated that the infection inhibitory molecules were maintained in the 10-100 kDa fraction 
and, less prominent, in the >100 kDa fraction. No inhibition of adherence was observed for the <10 
kDa fraction (data not shown).  
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Fig. 4: Inhibition of epithelial cell adherence by serum glycoproteins and glycolipids.  
Chang epithelial cells (left panel) and HD-11 chicken macrophages (right panel) were infected with ORT strains 
29 (open bars) and 30 (hatched bars) preincubated for 30 min with the indicated amounts of the isolated serum 
glycoprotein or glycolipid fractions. At 3 h of infection in the absence of serum components, bacterial adherence 
was determined and expressed as the average number of bacteria per cell. Values are the mean ± SEM of three 
experiments. Note that both the serum glycoprotein and glycolipid fraction exhibited infection inhibitory activity 
towards epithelial cells but not macrophages. 
 
Direct binding of serum glycoproteins to ORT strains 30 and 41 
To further unravel the mechanism by which serum factors influence the binding properties of 
ORT, we measured the direct binding of the isolated size-fractionated serum glycoproteins to the 
bacteria. For this purpose, serum glycoproteins were biotinylated to enable assessment of their 
interaction with ORT. Glycoprotein binding was measured by incubation ORT strains 30 and 41 (108 
bacteria/ml) with 50 µg of biotinylated glycoproteins for 30 min. Then, the bacteria were washed to 
remove unbound molecules. SDS-PAGE and Western blotting with streptavidin-horseradish 
peroxidase as a conjugate identified the biotinylated serum factors that had been bound by bacteria. 
These binding assays indicated direct binding of several biotinylated serum proteins of the 10-100 kDa 
fraction but not the >100 kDa fraction, to the bacterial cell surface (Fig. 5). Several proteins bound to 
strain 41 but not to strain 30 that differs in epithelial cell adherence and haemagglutination properties. 
 
 
 
 
 45
Chapter 4 
   
 
113
176
80
63
49
37
26
kDa
21 3 54 6 7 8
 
Fig. 5: Direct binding of serum glycoproteins to ORT. 
ORT strains 30 (lanes 2, 5 and 7) and 41 (lanes 3, 6 and 8) were incubated without (lanes 7 and 8) or with 
biotinylated isolated serum glycoproteins with a molecular size of >100 kDa (lanes 2 and 3) or between 10-100 
kDa (lanes 5 and 6). After removal of unbound material, the bacteria were subjected to SDS-PAGE and blotted 
onto nitrocellulose. Serum proteins bound to ORT were detected with horseradish peroxidase-conjugated 
streptavidin with the appropriate substrate. The >100 kDa and 10-100 kDa fractions of biotinylated serum 
glycoproteins that were added to the bacteria were run for comparison and are in lanes 1 and 4, respectively. 
Note that binding activity was observed for several proteins of the 10-100 kDa fraction with some differences 
between strain 30 and 41, which may be related to the different, but serum-sensitive adherence properties of 
these strains. 
 
Comparison of the inhibitory effects of serum and LPS on ORT infection 
We previously demonstrated that purified LPS of ORT was capable to inhibit the adherence of the 
homologous strain to cultured epithelial cells but not macrophages (Chapter 2 and 3). As the serum 
inhibition appears to show a similar cell type specificity and likely involves by carbohydrates residues,  
we tested whether the effect of LPS was also caused via binding of the (bacterial) glycolipid to ORT. 
Infection assays in which either the bacteria or epithelial cells were preincubated with LPS 
demonstrated that purified LPS derived from strain 30 was able to inhibit bacterial adherence of this 
strain when the bacteria but not the host cells were primed with LPS (Fig. 6A). This effect was not 
observed when LPS of strain 29 was used as an inhibitor. Similarly, the LPS of strain 29 inhibited the 
binding of strain 29 when the bacteria but not the host cells were primed with the LPS, while the LPS 
derived from strain 30 had no effect (Fig. 6A). Thus, although both serum and LPS block ORT 
adhesion to epithelial cells via an effect on the ORT, the effect of LPS but not serum exhibits strain 
specificity. This suggests that related but different carbohydrates may confer the infection inhibition 
by serum and LPS. 
To further assess whether LPS and serum exhibited their effect through binding to the same or 
different bacterial ligands, a competitive binding assay was employed. ORT strains 29 was incubated 
with biotinylated purified serum protein with and without prior priming (15 min, 37oC) with purified 
endogenous LPS or serum. SDS-PAGE and immunoblotting of these samples showed that serum but 
not LPS competed for the binding of the biotinylated serum glycoproteins (Fig. 6B). Similar results 
were obtained for strain 30. (not shown). These data are consistent with LPS and serum exerting their 
inhibitory effect via different mechanisms. 
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Fig. 6: Strain specific inhibition of ORT adherence by LPS. 
(A) Chang epithelial cells were infected with ORT strain 29 (solid bars) or strain 30 (hatched bars) preincubated 
with buffer (control) or 10 µg of LPS derived from strain 29 (LPS29) or strain 30 (LPS30). Then, Chang 
epithelial cells were infected with these bacteria in the absence of LPS. Infection was stopped at 3 h of 
incubation and the number of adherent bacteria was determined. Data are expressed as the average number of 
bacteria per cell. Values are the mean ± SEM of three experiments. Note the strain specific inhibition of 
adherence by LPS. (B) ORT strain 29 was incubated with biotinylated isolated serum glycoproteins with a 
molecular size between 10-100 kDa in the absence (lane 1) and presence of 10 µg of purified LPS of strain 29 
(lane 2) or 10% FBS (lane 3). After removal of unbound material, the bacteria were subjected to SDS-PAGE and 
blotted onto nitrocellulose. Bound were detected with horseradish peroxidase conjugated streptavidin with the 
appropriate substrate. Note that FBS but not LPS competed for binding of the biotinylated serum proteins to 
ORT. 
 
Differential inhibitory effects of serum and LPS on epithelial cell haemagglutination and 
adhesion of ORT strain 41 
When grown on Columbia agar plates, ORT strain 41 agglutinates chicken red blood cells but 
only poorly adheres to epithelial cells in contrast to ORT strains 29 and 30 (Chapter 2). To investigate 
whether the ORT induced haemagglutination was serum sensitive, haemagglutination assays with 
strain 41 in the absence and presence of 15% serum were performed. Serum effectively inhibited the 
ORT-mediated haemagglutination (Fig. 7). Similar experiments in the presence of LPS derived from 
strain 41 yielded unaltered haemagglutination compared to serum-free conditions. 
When grown in Todd-Hewitt broth, strain 41 gains the ability to adhere to epithelial cells and 
loses its haemagglutination properties (Chapter 2). Epithelial cell adhesion assays with broth-grown 
strain 41 in the absence and presence of 15% serum showed that serum inhibited ORT infection of the 
epithelial cells (Fig. 8) thus resembling the effect on the haemagglutination observed for solid phase 
grown ORT. Assessment of the possible inhibitory effect of LPS on the epithelial cell adhesion 
showed that endogenous but not heterogeneous LPS inhibited ORT infection of the epithelial cells 
(Fig. 8), although the effects were much less profound that those obtained for strains 29 and 30. This 
data support the conclusion that serum and LPS inhibit epithelial cell infection via related but different 
mechanisms and implies that ORT strain 41 possesses at least two cell-type (epithelial and red blood 
cell) specific adhesins that are both sensitive to serum but differentially sensitive to LPS. 
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Fig. 7: Sensitivity of ORT-mediated haemagglutination to serum but not LPS. 
Chicken red bloods cells (RBC) were mixed with serial dilutions of plate grown ORT strain 41 (ORT) in the 
absence or presence of 10 µg of isolated serum glycoproteins or 10 µg of LPS purified from strain 41. After for 2 
h of incubation (20oC), haemagglutination (HA) was scored. Note that the HA mediated by strain 41 was 
inhibited by the serum components but not by LPS. 
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Fig. 8: Effects of serum and LPS on ORT strain 41 mediated epithelial cell adherence. 
Chang epithelial cells were infected with liquid media grown ORT strain 41 in the absence (control) and 
presence of 10% FBS, or 10 µg of purified LPS derived from strains 30 or 41. At 3 h of infection, bacterial 
adherence was determined and expressed as average number of bacteria per cell. Data are the mean ± SEM of 
three infection assays. Note that the epithelial cell adherence of strain 41 is sensitive to FBS and, to a lesser 
extent, to endogenous but not heterologous LPS. 
 
 
DISCUSSION 
 
Adhesion of bacterial pathogens to eukaryotic cells is a key step in the establishment of most 
mucosal infections and thus an attractive target of infection intervention and prevention. Here we 
report that the emerging avian pathogen ORT carries multiple adhesins that confer cell-type specific 
interactions with epithelial cells, macrophages and red blood cells. The existence of various 
mechanisms of adhesion became apparent via the differential inhibitory effects of serum and LPS on 
the ORT-host cell interaction. The discovery that both serum factors and LPS inhibit the adhesion of 
ORT through binding to the pathogen may be instrumental in the identification of the nature of the 
adhesins. In addition, the infection inhibitors may have prophylactic potential by preventing the initial 
colonization of the epithelium. 
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The first indication of the existence of multiple mechanisms of ORT adhesion to eukaryotic cells 
came from the differential inhibition by serum of the bacterial adhesion to epithelial cells and chicken 
macrophages. The finding that serum factors block ORT adhesion to epithelial cells but not 
macrophages indicate the existence of multiple bacterial surface adhesins. This conclusion is further 
supported by the differential inhibitory effect of LPS on the adhesion of ORT to epithelial cells and 
macrophages. Identification of the nature of the adhesins awaits further investigation. Our data 
indicate that purified LPS and the factors in serum that bind to the bacteria may aid in the 
identification process. 
Another major challenge is to determine the nature of the inhibitory molecules in the serum. Our 
results indicate  that both the serum glycoprotein and glycolipid fraction contain infection inhibitory 
activity. This may point to the involvement of carbohydrates. Carbohydrates frequently serve as 
receptors for bacterial pathogens (Heumann and Roger, 2002) and it can be imagined that serum 
factors carry carbohydrates that show mimicry with the epithelial cells receptors exploited by ORT for 
bacterial adherence. The finding that serum exerts its infection inhibitory activity through direct 
binding to the bacterial surface is consistent with this hypothesis. Our attempts to identify the serum 
glycoproteins through analysis of the isolated biotinylated proteins to the bacterial surface were not 
conclusive as at least eight different proteins exhibited binding activity. At this time, it is uncertain 
whether these molecules share common carbohydrate moieties, bind to different receptors, or bind via 
a common intermediate molecule analogous to the glycosaminoglycan bridge recruitment mechanism 
(Duensing et al., 1999). Because of the observed cell type specificity, we currently favor the scenario 
that the serum inhibition is caused through binding to bacterial factors involved in the adhesion 
process rather than a non-specific steric hindrance of the adhesion event. 
The striking resemblance in cell-type specificity and nature of  inhibitory compounds in serum 
with those of LPS led us to hypothesize that serum and LPS may exert their effect via the same 
mechanism. Indeed, LPS was found to inhibit bacterial adhesion by influencing the adhesive 
properties of the bacteria rather than influencing the host cells. Several lines of evidence however, 
suggest that serum and LPS act via different mechanisms. First, the binding of biotinylated serum 
glycoproteins was effectively blocked by serum but not by purified LPS, and second, the inhibitory 
effect of LPS showed remarkable strain specificity in contrast to serum, suggesting the involvement of 
different molecules. The differential sensitivity of haemagglutination conferred by ORT strain 41 to 
serum and LPS support this conclusion, although it can be argued that haemagglutination and 
epithelial cell adhesion may be separate phenomena mediated via different bacterial factors. Support 
from this concept comes from the apparent switching of ORT strain 41 between a haemagglutination-
positive and epithelial cell adhesive phenotype, dependent on the growth conditions. These phenotypes 
are both sensitive to serum but only the epithelial cell adhesion is blocked by LPS. This indicates cell 
type specificity and the involvement of different bacterial factors.  
The molecular mechanism underlying the transition between the haemagglutination-positive  and 
epithelial cell adhesive phenotype of ORT strain 41 is not known. The finding that on solid media the 
bacteria are able to cause haemagglutination but that this property is replaced by an epithelial cell 
adhesive phenotype when the bacteria are grown in liquid media may indicate different expression of 
bacterial adhesions. Alternatively, it can be imagined that strain 41 produces a capsule when grown on 
solid media, which is lost when during growth in suspension. In this scenario, the epithelial cell 
adhesion may already be present but hampered in function by the capsule. In this case, the capsule 
may be responsible for the haemagglutination phenotype. Thus far, attempts to identify a capsular 
structure for ORT have not been successful. 
Perhaps the most intriguing and important aspect from our work is the potential application of the 
infection inhibitory factors in serum. It can be imagined that the active serum factors, once identified, 
can be applied to prevent initial ORT colonization and thus have prophylactic potential. In addition, 
the serum factors and also LPS may be applied to identify the bacterial factors that drive the 
colonization. These molecules may have great vaccine potential.   
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ABSTRACT 
 
The bacterium O. rhinotracheale has been recognized as an emerging pathogen for poultry about ten 
years ago. Knowledge of this bacterium and its mechanisms of virulence are still very limited. Here 
we report the development of a transformation system that enables genetic modification of O. 
rhinotracheale. The system is based on a cryptic plasmid, pOR1, that was derived from an O. 
rhinotracheale strain of serotype K. Sequencing indicated that the plasmid consisted of 14,787  
nucleotides. Sequence analysis revealed one replication origin and several rep genes that control 
plasmid replication and copy number, respectively. In addition, pOR1 contains genes with similarity to 
a heavy metal-transporting ATPase, a TonB linked siderophore receptor, and a laccase. RT-PCR 
demonstrated that these genes were transcribed. Other putative open reading frames exhibited 
similarities with a virulence associated protein in Actinobacillus actinomycetemcomitans and a number 
of genes coding for proteins with unknown function. An E. coli - O. rhinotracheale shuttle plasmid 
(pOREC1) was constructed by cloning the replication origin and rep genes from pOR1 and the cfxA 
gene from Bacteroides vulgatus, that codes for resistance to the antibiotic cefoxitin, into plasmid 
pGEM7 using E.coli as a host. pOREC1 was electroporated into O. rhinotracheale and yielded 
cefoxitin resistant transformants. The pOREC1 isolated from these transformants was reintroduced 
into E. coli, demonstrating that pOREC1 acts as an independent replicon, both in E.coli and O. 
rhinotracheale, fulfilling the criteria for a shuttle plasmid that can be used for transformation, targeted 
mutagenesis and the construction of defined attenuated vaccine strains. 
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INTRODUCTION 
 
The Gram-negative bacterium Ornithobacterium rhinotracheale was identified and recognized as 
a pathogen for birds in 1991 by DuPreez (van Beek et al., 1994). The bacterium normally causes 
infection of the respiratory tract, but may disseminate to other body sites resulting in osteitis, 
meningitis and joint-infections (van Empel et al., 1999). O. rhinotracheale infections in flocks occur 
worldwide and are increasingly recognized as a health problem in chicken and turkey farming. The 
major economic losses due to O. rhinotracheale infection result from the rejection of carcasses for 
consumption, growth retardation and mortality. O. rhinotracheale is a member of the 
Flavobacteriaceae that belong to the Cytophaga-Flavobacterium-Bacteroides phylum (Vandamme et 
al., 1994). Related pathogens are the bird pathogens Riemerella anatipestifer and Coenonia anatina 
(Vandamme et al., 1999).  
Infections with O. rhinotracheale can be successfully treated with antibiotics, but the bacterium 
rapidly develops antibiotic resistances (Devriese et al., 1995). Infections of O. rhinotracheale can 
spread both horizontally by aerosols and vertically via infected eggs. Vaccination against O. 
rhinotracheale infections with a bacterin has been found suitable for the prevention of infections by 
the vertical route, but to be effective the bacterin has to be administered with an oily adjuvant (van 
Empel and van den Bosch, 1998). To prevent horizontal transfer of the bacterium, vaccination with a 
live avirulent strain seems to be effective (van Empel and Hafez, 1999). The construction of 
genetically well-defined and attenuated strains however, is seriously hampered by the lack of tools to 
genetically manipulate the pathogen. For the related Flavobacteriaeceae a few tools have been 
developed (McBride and Baker, 1996) but these plasmids have been found not to be suitable for 
transformation of O. rhinotracheale (unpublished data).  
An attractive approach for the development of a plasmid that can be exploited for genetic 
manipulation of O. rhinotracheale isolates is to modify an endogenous O. rhinotracheale plasmid. 
One strain of O. rhinotracheale has been reported to carry such a plasmid (Back et al., 1997). Here the 
isolation and characterization of the native plasmid pOR1 from O. rhinotracheale and the construction 
of a shuttle vector that can replicate both in E. coli and O. rhinotracheale is reported. This shuttle 
vector paves the way for genetic modification and characterization of the O. rhinotracheale genome 
and for the development of genetically defined vaccine strains.  
 
MATERIALS AND METHODS 
 
Bacterial strains and culture conditions 
The strains of O. rhinotracheale used in this study (Table I) were kindly provided by Dr. P. van 
Empel (Intervet International, Boxmeer, The Netherlands). The characteristics of the strains have 
previously been described (van Empel et al., 1998). O. rhinotracheale strains were grown at 37°C in 
an atmosphere of 5% CO2 on Columbia agar plates (Oxoid, Basingstoke, England) or in Todd-Hewitt 
broth (Oxoid). The broth cultures were incubated on an orbital shaker (120 rpm) at 37°C in a tightly 
sealed 50 ml Falcon tube. 
 
Table I. Characteristics and origin of the O. rhinotracheale strains used in this study. 
 
strain  serotype bird country 
7 A guinea fowl France 
11 B turkey Germany 
12 B turkey the Netherlands 
18 B turkey Germany 
35 D turkey France 
45 E turkey Germany 
99-0118 K turkey USA (Minnesota) 
215 K turkey South Africa 
97-0321 K turkey USA (Iowa) 
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DNA isolation, hybridization, cloning and sequencing of pOR1 
Total genomic DNA from bacterial strains was isolated using the High Pure PCR template kit 
(Roche diagnostics, Nederland B.V., Almere, The Netherlands). Southern blot hybridization was done 
using Hybond N membranes (Amersham Biosciences, Roosendaal, The Netherlands). The probes 
were labeled with 32P dATP using the Random primer labeling kit (Boehringer Mannheim, Germany). 
The hybridizations were done at high stringent conditions with a final wash of 0.5 X SSPE at 65°C.  
 
Cloning and sequencing of pOR1 
The plasmid pOR1 was isolated from total genomic DNA from strain 99-0118 by CsCl gradient 
centrifugation (Sambrook et al., 1989) in a TL-100 ultracentrifuge (Beckman Palo Alto, Calif., USA). 
The full length pOR1 was cloned with its unique BamHI site into lambda EMBL3 phage (Promega 
corp., Madison, WI., USA) with E. coli JM109 as a host. The pOR1 DNA was subcloned as HindIII 
fragments into the pGEM7Zf(+) cloning vector (Promega corp., Madison, WI, USA) using E. coli 
DH5α as a host. Serial deletion clones for sequencing purposes were made using the Erase-a-base 
system (Promega corp., Madison, WI., USA). The DNA sequence was determined using the Big-Dye 
terminator system on a 310 Genetic Analyzer (Perkin Elmer Applied Biosystems, Foster city, Calif., 
USA).  
 
Expression studies on pOR1 genes 
Total RNA was isolated from O. rhinotracheale cultured for two days on a blood agar plates. 
RNA was isolated using RNasol B (Tel-Test, Friendswood, TX, USA) according to the manufacturers 
conditions. Residual DNA was removed from the RNA preparation using RQ1 RNase-free DNase 
(Promega). The reverse transcription (RT) of the RNA was done using the Access RT-PCR system 
(Promega). The RT reaction was done at 37°C during 60 minutes using the downstream primers 2, 4, 
or 6 (Table II). An aliquot of the RT reaction mixture was used in the PCR. The 35 PCR cycles were 
run at the following conditions; annealing at 55°C for 30 seconds, extension at 74°C for 1 minute, and 
melting at 94°C for 30 seconds. The primers that were used in the RT reactions are listed in Table II. 
 
Table II. PCR and RT-PCR primers used in this study 
 
PCR-primer Position in pOR1 Sequence Target gene 
16S-F  GAGAATTAATTTACGGATTAAG 16SRNA 
16S-R  TTCGCTTGGTCTCCGAAGAT 16SRNA 
rep  GAAAGGATTTAAGCGGAC rep2 
M13U  CACGACGTTGTAAAACGACGGCCAG  
RT-primer     
1 4599-4615 CGTGATAGATTACGGAG 
2 4832-4849 ATGATTGGACATTTAGCA 
siderophore receptor 
3 6759-6776 CCAATGTAAGAGGGAAAG 
4 7164-7181 GTATAGCAATGGGTGGAT 
Cd resistance 
5 10575-10592 CAACCGAAGACAGGACAC 
6 11210-11227 GAGGAAGGTGATTGGTTC 
Laccase 
    
7 EFGPup ACCCTCGTGACCACCCTGACCTAC efgP 
8 EFGPdown GACCATGTGATCGCGCTTCTCGTT efgP 
 
Heavy metal resistance 
Resistance to heavy metal ions was determined on Columbia agar plates with the heavy-metal 
salts CdCl2, CoSO4, CuSO4, and HgCl2 (Merck, Darmstadt, Germany) at concentrations of 0.01, 0.1, 1, 
or 10 mM. The plates were inoculated with the O. rhinotracheale strains and after two days of 
incubation the colonies were scored on a scale from 0 to 3 (0 = no colonies, 1 = visible colonies, 2 = 
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intermediate size colonies, 3 = similar colonies as the control). The Minimal Inhibitory Concentration 
(MIC) was defined as the lowest concentration at which scale 2 colonies were obtained.  
  
Construction of pOREC1 
The shuttle vector pOREC1 consists of pGEM7 with the replication origin of pOR1 and the cfxA 
gene of Bacteroides vulgatus (EMBL/Genbank accession number U38243). Construction of pOREC1 
was carried out in two steps. First, the replication origin of pOR1 was cloned as a BamHI/NdeI 
fragment of 2681 bp into the BamHI and EcoRI sites of pGEM7Zf(+). Prior to the ligation the NdeI 
and EcoRI sites were filled in by the Klenow fragment of DNA polymerase to obtain blunt ends. In the 
second step, the cfxA gene was cut from pCP29 as a BamHI/PstI fragment of 2.1 kbp (kindly provided 
by Dr. Sarika Agarwal, University of Wisconsin) and  ligated into the BamHI/NsiI sites of the former 
construct.  
 
Electroporation of O. rhinotracheale 
Transformation of O. rhinotracheale was done by electroporation using a GenePulser (BioRad, 
Uppsala, Sweden). Electrocompetent bacteria were prepared from bacteria grown for 2-days in 10 ml 
of Todd-Hewitt broth in 50 ml Falcon tubes on an orbital shaker (120 rpm, 37°C). The OD600 of the 
cultures was between 0.3 and 0.4. The cultures were washed two times with 25 ml of sterile distilled 
water and finally washed with 10% glycerol. The cell pellet was resuspended in approximately 100 µl 
of 10% glycerol resulting in a suspension of 109 to 1010 colony forming units per ml (cfu). 
Electroporation was done in disposable cuvettes with an electrode distance of 2 mm, using 40 µl of 
cell suspension and 5 µl of DNA solution containing approximately 1 mg/ml of DNA. All 
manipulations of the bacteria were done at room temperature. The settings of the GenePulser were: 25 
µF capacity, 2500 V and 800 Ohm parallel resistor. Directly after the pulse 960 µl of Todd-Hewitt 
broth was added and the bacteria were recovered for at least 90 min at 37°C. After recovery the 
bacteria were plated on selective plates (cefoxitin 5 µg/ml) and incubated for at least 3 days at 37°C 
and 5% CO2.  
The impact of the electric pulse was measured by the survival rate of the bacterial cells before and 
after the pulse. The survival rate was measured by comparing the cfu of serial dilutions of the cell 
suspension before and after the electric pulse. It was observed that the survival rate was close to 100%, 
which implicates that the O. rhinotracheale cell wall is resistant to electric pulse and probably difficult 
to be made permeable.  
 
PCR and RT-primers  
The primers used in a PCR to identify O. rhinotracheale on its 16S rRNA genes were: primer: 
16S-F and primer 16S-R. These primers amplify a 784 bp fragment of the 16S rRNA gene of O. 
rhinotracheale (accession number L19156). The primers used to identify the presence of pOREC1 in 
transformants were primer rep, which is located in the rep2 gene of pOR1 and primer M13U that is 
located in pGEM7Zf(+). The sequence of these primers and those of the primers used in the RT-PCR 
to demonstrate expression of pOR1 genes and EFGP are listed in Table II.  
 
Assembly and annotation of pOR1 sequence 
The nucleotide sequence of pOR1 was determined using a combination of subcloning and primer 
walking. The full length sequence of pOR1 was assembled from the single read sequences using the 
SeqMan program of the Lasergene package (DNAStar inc., Madison, WI, USA). The whole pOR1 
sequence was covered at least three times by single reads and each base was identified with a 
reliability of at least 95% (Q value larger than 20).  
The annotation of potential coding sequences was done by GeneMark.hmm at website 
http://dixie.biology.gatech.edu/GeneMark/heuristic.cgi (Besemer and Borodovsky, 1999) and with 
BlastX at website http://www.ncbi.nlm.nih.gov/blast/blast.cgi of the National Institute of Health. To 
predict the potential function of the genes, the encoded proteins were compared with the proteins of 
the EMBL/Genbank database using BlastP. Repetitive sequences and AT contents were determined 
using the GeneQuest program of Lasergene. The nucleotide sequence of the pOR1 plasmid is 
deposited in the EMBL/Genbank database under accession number AY513488. 
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RESULTS 
 
Cloning and prevalence of pOR1 among O. rhinotracheale isolates 
Plasmid pOR1 was isolated by CsCl density gradient centrifugation. The plasmid banded at a 
higher density than genomic DNA, indicating that pOR1 is circular and supercoiled. The entire 
plasmid pOR1 was cloned into lambda phage EMBL3, using its unique BamHI site.  
The occurrence of pOR1 among O. rhinotracheale isolates was investigated by screening total 
DNA of a panel of O. rhinotracheale isolates by dot-blot DNA hybridization using the full length 
pOR1 clone in lambda EMBL3 phage as a probe. The O. rhinotracheale strain 99-0118 that carries 
pOR1 originates from Minnesota and has the rare serotype K. The panel consisted of two other 
isolates that have serotype K, 34 non-K serotype isolates that originated in Minnesota and 20 isolates 
that were isolated from different bird species from Europe and Africa. In one of the other serotype K 
strains (97-0321) that originate in Minnesota, pOR1 sequences were detected. All other isolates 
including the serotype K isolate (215) from South Africa yielded no positive signals under the 
conditions employed. Southern blot analysis on the HindIII digested DNA from isolates 99-0118 and 
97-0321 using pOR1 as a probe yielded identical patterns for both strains (data not shown). This 
indicates that both strains carry pOR1.  
 
Determination and annotation of pOR1 sequences 
The nucleotide sequence or pOR1 comprised 14,787 bp. The plasmid has a GC content of 35.7%, 
which is similar to the 37 to 39% reported for the whole genome of O. rhinotracheale (Vandamme 
1994). The AT and GC nucleotides are unevenly distributed on the plasmid. Part of the plasmid, 
encompassing the putative genes 4 to 9 (see below) have a higher GC content (38.8%) than the 
remainder of the plasmid (31.2%), which might indicate that pOR1 has a mosaic composition. 
The putative genes on the plasmid were identified using the GeneMark.hmm program (Besemer 
and Borodovsky, 1999). Thirteen regions that start with an initiation codon with the potential to 
encode a  protein of more than 100 amino acids were found on pOR1. A map of the putative genes of 
pOR1 is presented in Fig. 1. Genes encoding proteins less than 100 amino acids were only included 
when they had significant homology to a protein sequence in the database. The vapD gene is therefore 
included in Fig.1 and Table III, whereas two other genes encoding proteins less than 100 amino acids 
are excluded. To attribute a function to the putative genes, the encoded proteins were compared with 
the EMBL/Genbank database using BlastP. The genes from the database with the best match to the 
putative genes are listed in Table III. 
 
Table III. Characteristics of putative genes of pOR1. 
Orf Gene Similar gene product Probable function e-value PID Species 
1 repA replication protein A 3e-72 g1075495 Bacteroides vulgatus 
2 rep2 replication protein 2 
plasmid replication 
3e-24 g10956802 Riemerella anatipestifer 
3 trans transposase transposition 1e-41 g16082872 Yersinia pestis 
4  no similarity     
5  tonB-linked outer 
membrane receptor 
iron uptake 2e-33 g29345912 Bacteroides 
thetaiotamicron 
6 yvgW heavy metalion-transporting 
ATPase 
cadmium efflux 1e-159 g21398552 Cytophaga hutchinsonii 
7  no similarity    n.a 
8 merP periplasmic transport 
protein 
mercury efflux 6e-04 g2935549 Pseudomonas alcaligenes 
9 mlpB putative lipoprotein unknown 2e-19 g4467968 Myxococcus xanthus 
10 pcoA copper resistance protein  copper binding 1e-72 g13632794 Escherichia coli 
11  chromosome assembly 
protein homologue 
chromosome 
assembly 
0.002 g15606061 Aquifex aeolicus 
12 mbpB mobilization protein plasmid 
mobilization 
2e-10 g915338 Bacteroides fragilis 
13  no similarity     
14 vapD virulence associated protein unknown 2e-24 g6136169 A.actinomycetemcomitans 
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ion (orfs 1 and 2), heavy metal metabolism (orfs 5 to 10) and mobilization (orfs 11 and 12).  
en reading frames 1 and 2 are homologous to the replication genes repA and rep2 of 
ides vulgatus and R. anatipestifer plasmids, respectively. These Rep proteins are usually found 
ids with a theta-form replication mode (Chattoraj, 2000). In front of the repA gene four 
ct repeats can be recognized that may function as the iteron and regulates plasmid replication 
. No other iteron sequences are present elsewhere on the plasmid. The replication origin of the 
 is most likely located in front of the iteron (del Solar et al., 1998). The region of 262 bp 
he iteron has a high AT content (76%) characteristic of plasmid replication origins.  
f 3 encodes a protein of 201 amino acid residues. This protein is similar to the proximal half of 
number of bacterial transposases and encodes about 400 amino acid residues. Therefore, orf 3 
likely the truncated transposase of an IS element. 
f 5 encodes a protein that is highly similar to TonB linked siderophore receptors. Siderophore 
rs allow the bacteria to recruit iron from the environment.  
e proteins encoded by orfs 6 to 10 show similarities to proteins that are involved in resistance 
y metal ions. Orf 6 is highly similar to numerous bacterial heavy metal ion-transporting 
s of the CPx-type ATPase family. These proteins facilitate efflux of heavy metal ions such as 
m, cobalt and copper across the bacterial cell envelope (Williams and Pittman, 2000). The 
rf 7 has no significant similarity to any proteins of the databases. The 291 amino acid residues 
 by orf 8 have similarity to the MerP protein that is involved in mercury resistance. However, 
likely that orf 8 codes for a MerP protein as these proteins are much smaller than the orf 9 
 Metallothioneins are approximately 90 amino acid residues in length. In addition, the merP 
re part of an operon encoding proteins that are involved in sensing, transport and reduction of 
 ions. The orf 9 protein is similar to a single protein MlpB of Myxococcus xanthus. No 
 was attributed to MlpB that renders the function of  the orf 9 protein enigmatic.  
e protein encoded by orf 10 has a high similarity to two groups of proteins. The highest 
ty (e-154) was found with bacterial proteins involved in copper resistance such as PcoA of E. 
 CopA of Xanthomonas campestris and Pseudomonas species. A lower, but very significant 
ty (4e-37) was found with the large family of the laccases. Laccases are enzymes (EC 1.10.3.2) 
 widely distributed among bacteria and fungi (Liu et al., 1999). The laccases require copper 
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binding for activity. The orf 10 protein has the four copper binding domains that are found in all 
laccases (see annotation at EMBL/Genbank AY513488 and at website 
www.llu.edu/llu/medicine/micro/laccase/), which strongly suggests that the orf 10 protein is a laccase. 
The proteins encoded by the orfs 11 and 12 may form a functional unit that is involved in plasmid 
mobilization. The functional entity of these genes is also reflected by their reverse orientation with 
respect to the other genes of pOR1. The protein encoded by orf 11 has a weak similarity to a putative 
chromosome assembly protein of A. aeolicus, but orf 12 shows a clear similarity to the plasmid 
mobilization proteins MbpB of B. fragilis.  
The protein encoded by orf 14 is similar to the Virulence Associated protein D (vapD) that is 
present in at least thirteen bacterial species among which are some known bird pathogens like 
Riemerella anatipestifer. Although, the name of these proteins suggests involvement in bacterial 
virulence, no function has been attributed to these proteins. 
 
Transformation of O. rhinotracheale and construction of a shuttle vector 
To establish a transformation system for O. rhinotracheale, an E. coli-O. rhinotracheale shuttle 
vector was constructed. This shuttle vector pOREC1 was made by cloning the putative replication 
origin, the iteron and the repA and rep2 genes (orfs 2 and 3) needed for replication in O. 
rhinotracheale into pGEM7. As a selection marker the cefoxitin resistance gene cfxA from 
Bacteroides vulgatus was included. A map of the shuttle vector pOREC1 is presented in Fig 2.  
Transformation of O. rhinotracheale was achieved by electroporation with 0.5 µg pOREC1 that 
was isolated from E. coli. Several O. rhinotracheale strains were subjected to electroporation with 
pOREC1 and cefoxitin resistant colonies were found after four days incubation. The efficiency of the 
transformation was approximately 400 recombinants per µg of plasmid DNA. No strain differences 
were found in the efficiency of transformation. The presence of pOREC1 in the recombinant O. 
rhinotracheale was confirmed by PCR using primers M13U and primer rep (Fig. 2). In addition, 
recombinants were verified as O. rhinotracheale by a species specific PCR on the 16S rRNA gene 
with primers OR16S-F and OR16S-R. Transformation of E. coli with total DNA of the O. 
rhinotracheale recombinants again resulted in transformed E. coli with pOREC1. This indicates that  
pOREC1 was present in O. rhinotracheale as an independent replicon. The transformation of both O. 
rhinotracheale and E. coli with pOREC1 demonstrates the functionality of the replication origin and 
rep genes of pOR1.  
 
 
pOR1 ori cfxA 
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pOREC
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EcoRI/NdeI
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 Beta-lactamase 
 
Fig. 2. Organization of the shuttle plasmid pOREC1. Boxes represent the genes that are involved in replication 
and selection in O. rhinotracheale (repA, rep2 and cfxA) and E. coli (beta-lactamase). The restriction sites that 
were used in the construction of pOREC1 are indicated.  
 
Expression of heavy metal resistance encoding genes of pOR1 
RT-PCR was used to test the expression of three of the functionally related genes of pOR1. The 
three genes are orf 5 encoding the putative TonB linked siderophore receptor, orf 6 encoding the 
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putative heavy metal-transporting ATPase, and orf 10 encoding the putative copper resistance or the 
putative laccase. RT-PCR was carried out on total RNA from strain 99-0118 grown on agar plates for 
two days. RT-PCR products were obtained for the all three genes, indicative of gene transcription (Fig. 
3).   
The functionality of the putative heavy metal metal-resistance protein encoded by orf 6 was tested 
on its ability to protect O. rhinotracheale from toxic heavy metal ions. Strains 99-0118 and 97-0321 
that carry pOR1 were exposed to various concentrations of the heavy metal ions cobalt, chromium, 
cadmium, mercury, and copper.  Strain 215 of serotype K, strain 7 of serotype A, and strains 11 and 18 
of serotype B, that all lack pOR1, served as control in these experiments. The growth of the six strains 
was fully inhibited by mercury (0.05 mM),  while cobalt and chromium were not inhibitory to the O. 
rhinotracheale strains at a concentration of 1 mM. Cadmium inhibited growth of the three serotype K 
strains at 0.05 mM, while the three non-serotype K strains were inhibited at the lower concentration of 
0.01 mM cadmium. Copper inhibited the growth of the four strains that do not carry pOR1 at 
concentrations of 0.5 mM, while the two pOR1 carrying strains were inhibited at concentrations ten 
times higher (5 mM). Mercury ions inhibited growth of all strains at concentrations of 0.05 mM. These 
data indicate that the putative heavy metal ATPase of pOR1 hardly protects the bacteria from heavy 
metal toxicity. Only a slightly higher copper resistance is correlated with the presence of pOR1. The 
higher cadmium resistance of the plasmid carrying stains is unlikely correlated with the presence of 
the plasmid, since strain 215 that has the same serotype K but not pOR1 exhibited similar levels of 
resistance to cadmium. 
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Fig. 3. Transcription of pOR1 genes. Ethidium bromide stained agarose gel of DNA fragments amplified by RT-
PCR of genes located on pOR1 in O. rhinotracheale strain 99-0118. Lanes 1, 2, and 3, RT-PCR products of the 
putative siderophore receptor, Cd resistance gene and the laccase respectively. Lanes 4, 5, and 6 PCR on the 
cloned pOR1 sequences. Lanes 7, 8, and 9, RT-PCR on the RNase treated RNA preparation. The molecular 
weightmarker (M) was EcoRI and HindIII digested phage lambda DNA. The fragment sizes of the marker in bp 
are indicated. 
 
Expression of enhanced green fluorescent protein (EGFP) on pOREC1 
The expression of the EGFP by O. rhinotracheale can be a useful tool to monitor the tissue 
localization of the bacteria after experimental infection of cultured cells and animals. The gene 
encoding the EGFP protein was cloned into pOREC1 between the replication origin of pOR1 and the 
pGEM7 part of the shuttle vector (Fig. 2). The EGFP gene was placed under the control of the lac 
promoter. It was demonstrated by RT-PCR using EGFP specific primers that transcripts of the EGFP 
gene were present in O. rhinotracheale transformed with the pOREC1-EGFP construct, demonstrating 
that the lac promoter is active in O. rhinotracheale. However, the bacteria that transcribed the EGFP 
gene did not show any fluorescence. The absence of fluorescence likely resulted from inefficient 
translation of the mRNA possibly because the codon usage of EGFP is not suitable for O. 
rhinotracheale. The codon usage of the genes from plasmid pOR1 differs strongly from the codon 
usage of EGFP. Most notable is that only 3.6 percent of the EGFP codons have an A or T residue at 
the first position while the codons of the native O. rhinotracheale genes have 58% A or T at the first 
position.  
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DISCUSSION 
 
In this report the successful transformation of O. rhinotracheale using a newly constructed 
plasmid shuttle vector pOREC1 is described. The transformation of O. rhinotracheale for the first time 
paves the way to genetic manipulation of this bacterium and will aid in a better understanding of the 
virulence of this bird pathogen. The genetic manipulation of O. rhinotracheale also may aid in the 
development of a vaccine strain by directed mutagenesis of O. rhinotracheale leading to defined 
attenuated vaccine strains.  
The bacterium O. rhinotracheale has been subjected to numerous fruitless attempt for 
transformation using shuttle vectors from other Flavobacteriaceae and wide host range plasmids (R 
Jansen, unpublished data).  Most likely this lack of success can be attributed to the failure of the 
introduced plasmids to replicate within O. rhinotracheale, since for these other vectors the same 
transformation protocol and the same selection marker, the cfxA gene, as for pOREC1, were 
employed.  
In the construction of the functional shuttle plasmid pOREC1, the replication origin, iteron and 
the two putative replication genes repA and rep2 of pOR1 were used. The presence of two replication 
genes, repA and rep2 is uncommon for plasmids with theta-like replication. Most of these plasmids  
have a single repA gene. A second replication gene similar to rep2 is also present on pCFC1 of 
Riemerella anatipestifer and on pUCL287 of Tetragenococcus halophilus (Benachour et al., 1997; 
Weng et al., 1999). In T. halophilus the Rep2 protein is not essential for replication, but involved in 
copy-number control and segregational stability (Benachour et al., 1997). It can be imagined that rep2 
of O. rhinotracheale has a similar function.   
The plasmid pOR1 was detected in only two isolates of the numerous O. rhinotracheale strains 
that were analyzed. These two isolates might represent the same strain, since both isolates originate 
from the same geographical region and have the rare serotype K. The apparent rare occurrence of 
pOR1 suggests that the plasmid was introduced into O. rhinotracheale on a single recent occasion and 
has not spread in the population. The selective advantage for the bacterium of carrying pOR1 is 
unclear. Apart from the replication genes, for three genes the advantage for the bacterium can be 
speculated on. Firstly, the putative laccase might be a virulence factor for O. rhinotracheale as was 
suggested for the pathogenic fungus Cryptococcus neoformans (Liu et al., 1999). The laccase of C. 
neoformans possibly is involved in protection of the pathogen against killing by alveolar macrophages. 
The laccase prevents the production of hydroxyl radicals by oxidizing Fe(II) of Fe(III) in the 
macrophage. However, attempts to demonstrate laccase activity in O. rhinotracheale, using the 
polymerization activity of the laccase in pigment formation failed (R. Jansen unpublished data). The 
activity of other bacterial laccases also is enigmatic and the assays that were developed for plant and 
fungal laccases are not suitable for the bacterial family of laccases.  
The second gene that may be beneficial for O. rhinotracheale is the heavy metal-transporting 
ATPase. This enzyme may aid the bacterium to scavenge for copper, an essential component of the 
laccase. Our experiments did not reveal such a function as inferred from the equal sensitivity of the 
various strains to the heavy metals cadmium and mercury. The slightly higher resistance to copper that 
was observed is unlikely to have physiological significance considering the extremely high 
concentrations (0.5 mM) at which the effect became apparent.  
The third gene that might be advantageous to the bacterium is the TonB linked siderophore 
receptor encoding gene. The corresponding protein might aid the bacterium to scavenge for iron, 
which is essential for bacterial growth or, alternatively, for copper to aid the laccase activity.  
Clearly, the most important conclusion from the present work is that transformation of O. 
rhinotracheale is feasible and that the developed transformation system can be exploited to genetically 
modify the bacterium. The efficiency of transformation with the shuttle vector pOREC1 is still rather 
low and needs improvement for efficient use in, for instance, transposon mutagenesis or DNA 
displacement by homologous recombination. The low efficiency of transformation is likely caused by 
to the rather poor permeabilization of the O. rhinotracheale  membrane during electroporation and/or 
by restriction of the entering plasmid DNA. Optimization of the electroporation protocol may be 
achieved by growing the bacteria under conditions that weakens the cell wall. 
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1. Context and aim of the study 
 
The first steps following the discovery of a novel bacterial pathogen usually focus on the 
microbiological characterization of the infectious agent, the description of the associated pathology, the 
development of diagnostic tools, and simple measures to contain the spread of the pathogen. 
Ornithobacterium rhinotracheale (ORT) has emerged as a pathogen in turkeys and chickens about 20 
years ago and since then indeed all research efforts have been directed at developing new diagnostics and 
on the treatment and prevention of the highly contagious ORT infections. Nowadays ORT causes 
considerable economic losses to the poultry industry and the excessive use of anti-microbial drugs to 
contain ORT has resulted in a widespread resistance to many commonly used antibiotics. Several rather ill 
defined vaccines have been developed that show moderate efficacy but hold promise that vaccination may 
be an effective tool to provide full protection against ORT infection. The work described in this thesis was 
initiated to better understand the pathogenesis of ORT infection in the belief that knowledge of the 
bacterial and host determinants that contribute to the establishment of ORT infections would provide a 
solid basis for the development of well-defined and effective vaccines and possibly novel infection 
intervention methods. 
At the start of the work described in this thesis, no information regarding any aspect of the 
pathogenesis of ORT infections was available. Pathological examination of infected animals suggested 
that the bacteria colonized the respiratory epithelium (Back et al., 1998; van Empel et al., 1999) and 
interacted with macrophages (van Empel et al., 1999). The specific objectives of the present study were to 
better understand this interaction of ORT with epithelial cells and macrophages, to access the host cell 
response, and to develop a genetic tool that would enable genetic manipulation of the pathogen. The latter 
is essential to facilitate targeted mutagenesis and for the construction of attenuated strains with vaccine 
potential.  
 
2.  Interaction of ORT with epithelial cells 
 
Bacterial adherence to mucosal epithelium is the initial and most important step in the establishment 
of most mucosal infections. The interaction of ORT with epithelial cells was investigated using cultured 
epithelial cells as a model system. This approach is attractive as it simplifies the infection to the direct 
interaction of the pathogen with the target cells. At the same time this approach is flawed as it neglects the 
complexity of the natural setting of the infection. Nevertheless, the focus on the cellular infection revealed 
potentially important information regarding the kinetics of the infection, the molecules involved, and the 
variability among ORT strains.     
A primary finding was the rapid and efficient adherence of ORT to several types of cultured epithelial 
cells (Chapter 2). This for the first time indicated that ORT has the intrinsic machinery to adhere to 
eukaroytic cells. The fact that ORT adherence was established with epithelial cells of human origin may 
indicate that ORT does not show host specificity with regard to its initial epithelial cell adherence. The 
adherence properties of ORT towards epithelial cells derived from poultry could not be investigated due to 
a lack of existing cell lines. If indeed ORT epithelial cell adherence does not show host specificity this 
may imply that the bacterium may colonize other species than birds. This has not been seriously 
investigated and may easily be missed when colonization is not associated with pathology.  
The nature of the bacterial and host molecules involved in the cellular infection of epithelial cells 
remains to be defined. In this fishing expedition, the observation that not all ORT strain were capable to 
adhere to the epithelial cells (Chapter 2) may proof to be of value. The finding that ORT strain 41 only 
poorly adhered to the epithelial cells when grown on agar plates but gained this trait when grown in 
suspension suggests that the bacterial adhesin may not be invariably exposed at the bacterial cell surface. 
At this time it is uncertain whether the observed growth environment-dependent adhesive properties are 
caused by a variable expression of the bacterial adhesin or a masking by other surface structures such as a 
capsule. For Pasteurella multocida, which belongs to the same rRNA V superfamily, capsular hyaluronic 
acid appears to act as an adhesin (Lee et al., 1994). This bacterial polysaccharide confers adherence via 
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binding to a specific host cell glycoprotein receptor (Pruimboom et al., 1996). For other bacterial 
pathogen however, polysaccharide capsules have been reported to prevent efficient bacterial adherence by 
masking bacterial surface adhesins (de Vries et al., 1998). Detailed comparison of the surface 
characteristics of ORT strain 41 grown under various environmental may provide more information which 
mechanism account for the variable adhesion of this strain. 
An important observation that provided more information about the factors that confer ORT adhesion 
to epithelial cells was the inhibition of the event by endogenous but not heterologous ORT LPS (Chapter 
2). These data point to the involvement of carbohydrates in the adhesion process. The effect of LPS was 
mediated through an interaction of LPS with the bacteria rather than the host cells, which makes it 
tempting to speculate that LPS of ORT acts as a receptor analogue preventing the interaction of the 
bacterial adhesin with the epithelial cell receptor. A problem with this attractive scenario is that it implies 
that each of the ORT strains tested interacts with a different host receptor as the observed inhibitory effects 
of LPS were found to be strain-specific. Clearly, resolving the mechanism by which LPS inhibits ORT 
adhesion may provide important information about the nature of bacterial adhesins and the corresponding 
host cell receptors. 
In many bacterial mucosal infections, bacterial adherence is followed by entry and transcytosis or 
survival of the microorganism inside the host cell. Based on microscopy observations (Chapter 2), ORT 
appears not very efficient in inducing its own uptake into epithelial cells, at least under the conditions 
employed. Measurement of intracellular survival of ORT was seriously hampered by the lack of an 
appropriate survival assay. The commonly used gentamicin killing assay, based on the ability of the 
antibiotic to kill extracellular but not intracellular bacteria, could not be applied as all ORT strains tested 
were resistant towards the antibiotic and no alternative drugs were found suitable. The possibly relatively 
moderate ability or ORT to breach the mucosal barrier may explain why ORT infections are often found in 
combination with other viral or bacterial infections. It can be imagined that these microorganisms or the 
associated inflammatory response, generate cell damage that facilitate ORT penetration of the mucosa, 
although alternative mechanisms such as an up-regulation of relevant host cell receptors, can be 
hypothesized. Co-infection experiments in which epithelial cells are primed with e.g. ND virus, prior to 
the addition of ORT may shed more light at this key issue.  
 
3. Interaction of ORT with macrophages 
 
Consistent with the pathology observations, ORT adhered to and became ingested by macrophages 
(Chapter 3). Although at first sight the interaction with the macrophages may seem to mimic that 
described for epithelial cells, the infection of both cell types appears to involve separate mechanisms. The 
main difference between the infections of two cell lines is their sensitivity towards LPS and serum factors. 
In contrast to ORT infection of epithelial cells, infection of macrophages was not inhibited by LPS or 
serum (Chapters 3 and 4). This strongly suggest that the infection of macrophages is mediated via 
different bacterial adhesins and / or host cell receptors. Again it should be emphasized that these results 
were obtained for established macrophage cell lines and thus do not necessarily hold for the diverse set of 
macrophages present at the various body sites. However, the fact that similar observations were made for 
chicken and mouse macrophages suggests that, at least with regard to the adhesion and uptake, the 
interaction with macrophages may follow the general principles described above. The intriguing question 
as to what is the fate of the ORT ingested by the macrophages could again not be addressed because of the 
lack of an appropriate intracellular survival assay. 
Macrophages play an important role in the host defense against invading microorganisms and part of 
their defense is based on the production of nitric oxide (NO) (Mellouk et al., 1994). As described in 
Chapter 3, infection of chicken macrophages with ORT was followed by an increased production of NO, 
although the response was much slower than was observed for E. coli and Salmonella Enteritidis. This 
slower response is consistent with the apparently rather moderate inflammatory response observed during 
ORT infection compared to e.g. E. coli infection of the respiratory tract. The differences in NO response 
between ORT and the other bacteria is likely based on the difference in stimuli that induce the stimulation 
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of NO production. In contrast to the effects of E. coli and S. Enteritidis, the stimulation of NO production 
by ORT was not inhibited by the lipid A neutralizing agent polymixin B. This suggests that it was not 
mediated by LPS but by another unknown stimulus. The lack of responsiveness towards ORT LPS seems 
not related to the structure of the LPS as purified LPS was capable to induce NO production. A likely 
explanation for the difference in LPS bioactivity among the different species may be the variable exposure 
of the LPS. The data suggest that in ORT the LPS remains firmly embedded within the outer membrane, 
while E. coli and S. Enteritidis may release membrane material into the environment. 
In contrast to the adherence of ORT, stimulation of NO production showed dramatic differences 
between chicken HD-11 cells and murine J774A.1 macrophages (Chapter 3). This finding suggests that 
bacterial adherence and stimulation of NO production are independent phenomena. The difference in NO 
responsiveness between macrophage lines is important as it may translate to the natural situation. It has 
been reported that LPS stimulated macrophages obtained from chickens with a different genetic 
background showed different levels of expression of the enzyme nitric oxide synthase as well as NO 
production (Hussain and Qureshi, 1997). Translated to ORT infection, the genetic differences in 
macrophage responsiveness may manifest as variation in pathology. It would be of interest to learn more 
about the variation in ORT associated pathology between chicken lines. 
 
4. Infection inhibitory activity of serum  
 
The importance of taking the complexity of the natural infection into account in studies on the 
pathogenesis of bacterial infections is illustrated once more by the observation that serum exhibits 
infection inhibitory activity towards ORT infection of epithelial cells (Chapter 4). This important finding 
may proof to be particularly valuable in the further identification of the bacterial adhesins and/or 
receptors that drive the initial colonization of ORT as well as in the prevention of colonization. The 
specificity of the serum inhibition for epithelial cells compared to macrophages clearly indicates that 
ORT carries multiple cell-type specific adhesins.  
The exact nature of the inhibitory compounds and the mechanism via which serum inhibits the 
infection remain to be resolved. The properties of the infection inhibitory activity were explored by 
biochemical analysis and binding assays with labeled purified molecules. This revealed that the activity 
co-purified with the serum glycoprotein and serum glycolipid fraction, suggesting that it may be 
contained in the attached carbohydrate moieties. Importantly, the serum compound(s) exerted their effect 
by influencing the adhesive properties of the bacteria rather than the host cells. Thus the mechanism 
appears to resemble that noted for the inhibitory effect of bacterial LPS. The inhibition by serum 
however, showed no strain specificity in contrast to LPS, and the binding of biotinylated isolated serum 
protein to the bacteria was blocked by serum but not LPS. This suggests that serum and LPS act through 
possibly related but different mechanisms. It may be noteworthy that a similar cell type-specific 
inhibition of infection by serum has recently been reported for the bacterial pathogen Listeria 
monocytogenes (Hertzig et al. 2003). In this study, L. monocytogenes invasion to the epithelial cells was 
reduced in the presence of human serum, while no effect was observed towards the infection of 
macrophages. The serum compounds responsible for this effect have not yet been resolved either. 
Serum also inhibited the haemagglutination caused by solid phase grown ORT strain 41. The 
molecular basis for this phenomena is uncertain, although it seem to be different than for the inhibition of 
the ORT - epithelial cell interaction as the haemagglutination was not blocked by LPS and the 
haemagglutination activity was lost when the bacteria gained their ability to adhere to epithelial cells 
(Chapter 4). The apparent presence of a different serum-sensitive epithelial cell adhesin and 
haemagglutinin, and of a serum-resistant adhesin that confers the interaction of ORT with macrophages 
indicates the existence of at least three different cell-type specific ORT adhesins. It is currently unknown 
what conditions promote the haemagglutination activity and whether all strain have the intrinsic 
capability promote haemagglutination. The occurrence of haemagglutination during the natural infection 
may contribute to the observed obstruction of the capillaries at the advanced stages of pulmonary 
infection.   
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5. Plasmids and the potential use of the E. coli - ORT shuttle vector 
 
Bacterial pathogenicity strongly depends on the repertoire of virulence genes carried by the 
pathogen. Knowledge of these genes and of the regulatory elements that control their transcription are 
crucial to understand the emergence of novel pathogens and to further delineate the bacterial strategies 
exploited to establish an infection. To accommodate this need, genetic tools to manipulate the bacterium 
are extremely helpful. For ORT, no such tools were available. Development of a system to introduce 
foreign DNA into ORT encountered major obstacles as plasmids derived from close or more distantly 
related bacterial species could not be introduced and propagated in ORT. A breakthrough in developing a 
genetic transformation system for ORT was achieved when parts of a rare cryptic plasmid (pOR1) of ORT 
were exploited as vector (Chapter 5).  
Use of parts of pOR1 as part of an E. coli - ORT shuttle vector required sequencing and extensive 
analysis of pOR1. The plasmid which could be identified in only two isolates among the numerous ORT 
strains that were analyzed, comprised 14,787 bp, and contained 14 open reading frames that encoded 
proteins of at least 100 amino acids (Chapter 5). The fact that the plasmid could not be detected in most 
clinical isolates suggests that it does not encode critical virulence determinants. Sequence analysis 
revealed that the plasmid may have a function in the transport of heavy metals but whether this is 
sufficient beneficiary to ORT to maintain can be questioned. 
The most interesting and useful part of pOR1 was the replication region that obviously contained all 
information to enable replication of the plasmid within ORT. Introduction of the putative replication 
origin, iteron, repA and rep2 genes into the vector pGEM7 yielded the shuttle vector pOREC1. This 
vector replicated in E. coli and could be transferred to various ORT strains by electrotransformation 
(Chapter 5). The introduction of the cefoxitin resistance gene (cfxA) and the selection of ORT 
transformants on the basis of this resistance demonstrated the potential of the shuttle vector as a vehicle 
to introduce foreign genes into ORT.  
To fully exploit the potential of the shuttle vector e.g. in allelic recombination experiments, the 
problem of the rather low efficiency of transformation has to be addressed. The low frequency of 
transformation is probably caused by the rigidity of the bacterial membrane as survival assays following 
electroporation demonstrated limited bacterial killing indicative of a poor permeabilization of the 
membrane. This problem may be solved by weakening the cell wall prior to transformation e.g. with the 
help of lysozyme or antibiotics. Whether additional restriction barriers between E. coli and ORT also 
contribute to the low transformation efficiency remains to be determined. 
A second problem that may arise in the utilization of pOREC1 is the poor translation of foreign 
proteins. This is likely caused by the abnormal codon usage of ORT compared to many other bacteria. 
This problem became apparent after the failed construction of fluorescent ORT via the introduction 
pOREC1 carrying the EGFP gene. Although the gene was transcribed and thus contained a functional 
promoter, no protein could be detected. Obviously, this problem does not exist for use of the shuttle 
vector for targeted mutagenesis purposes or complementation studies in which mutated strain are 
complemented in trans with an intact copy of the disrupted ORT gene.    
Despite its limitations that likely can be solved in the near future, the developed E. coli - ORT shuttle 
vector has great potential. The vector can be exploited for random and targeted mutagenesis and 
complementation studies, and thus nicely complements the functional approach followed in the most part 
of the present work. In addition, the vector may be used to construct attenuated strains that can be used as 
vaccines.  
 
6. Implications for infection intervention and prevention 
 
ORT causes disease in chickens and turkeys with considerable economic losses due to lower 
production, growth retardation and high mortality rates that range from 2 to 11% in chickens (Chin and 
Droual, 1997; Hafez, 1996) and to sometimes even up to 50% in older turkeys (DeRosa et al., 1996; 
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Tahseen, 1997). The rapid emergence of antibiotic resistance as illustrated by the 80-100% resistance of 
ORT strains collected from 45 different broiler farms (Devriese et al., 2001), indicates that future 
containment of ORT via the use of antibiotics is no option. The only way to control the disease seems to 
be vaccination. Vaccination of broiler breeders has been demonstrated to induce long-standing immunity 
that protected the progeny against experimental challenge with ORT for 30 days (van Empel and van den 
Bosch, 1998). Similarly, live or killed ORT vaccines seem to protected susceptible turkeys against 
development of pathologic lesions (Bock et al., 1997; Sprenger et al., 2000). In a novel approach, Lopes 
et al. (2002a; 2002b) selected a temperature-sensitive (Ts) mutant of ORT for use as a live vaccine. This 
vaccine is based on the ability of the mutant to colonize the upper respiratory tract but not the lower 
respiratory tract and other organs of the birds. The Ts vaccine elicits a secretory immune response (IgA) 
and protects against challenge. Despite these promising results the current vaccines appear to provide 
protection against a limited window of strains. In addition, their composition and mechanism of action 
are ill-defined, leaving room for the emergence of vaccine resistant strains. 
The research approach and results described in this thesis are the first steps towards better 
understanding of the molecular events that attribute to the establishment of an infection. This work 
should provide a solid basis to guide future vaccine development by targeting key molecules of infection. 
Our data suggest that ORT carries at least three different adhesins that confer cell-type specific interaction 
with epithelial cells, macrophages and red blood cells, respectively. For vaccine purposes, identification 
of the adhesion that confers adherence to epithelial cells seems of most interest. The finding that this 
interaction can be inhibited by purified ORT LPS and serum factors provides the optimal setting to 
identify and purify the adhesin. Subsequent ORT challenge studies should demonstrate the vaccine 
potential of the adhesin. The function of the molecule can further be demonstrated via analysis of the 
behavior of defined ORT mutants that can be constructed with the developed ORT transformation system. 
When the mutants are compromised in their ability to colonize birds, the attenuated strain may be tested 
for its vaccine potential. At the same time, a more random genetic approach may be followed to identify 
additional vaccine candidates that e.g. do not infect macrophages or colonize without causing pathology.   
Complementary to the vaccine approach, it seems appropriate to further elucidate the mechanisms 
via which serum and LPS inhibit epithelial cell infections as these properties can be exploited to prevent 
ORT infection. As the infection inhibiting serum factors are a natural compound and target the bacteria 
rather than the host cell, they likely exert their effect without toxicity. The greatest challenge to fulfill this 
dream is probably to deliver the compound(s), once identified, at sufficient high concentration at the 
appropriate niche.  
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Summary 
 
Since its discovery, about 10 years ago, the bacterium Ornithobacterium rhinotracheale (ORT) has 
emerged as a serious pathogen of turkeys and chickens. The bacterium possibly made its transition from 
wild birds to domesticated poultry about twenty years ago. In poultry, ORT has been associated with 
clinical signs of respiratory distress, as well as more systemic infections, including arthritis and 
meningitis. Nowadays ORT causes considerable economic loss to the poultry industry and much effort is 
given to treat and prevent the disease. The diagnosis of ORT infection is based on relatively non-specific 
clinical signs, in combination with the isolation of the bacterium and/or serology but many infections are 
probably frequently missed. Treatment of the disease is complicated by wide spread resistance of ORT to a 
number of antibiotics. Several vaccines have been developed, which seem to provide protection against a 
limited number of serotypes. The present study was designed to better understand the pathogenesis of the 
infection, in the belief that, in the long run, solid scientific knowledge of the mechanisms that contribute 
to the establishment of an infection could be the best basis for the development of novel infection 
intervention and prevention strategies. 
In Chapter 2, the primary interaction of ORT with epithelial cells was studied at the cellular level. 
ORT efficiently adhered to epithelial cells in a dose-dependent fashion, reaching levels of up to 80 bacteria 
per cell. Comparison of the adhesive properties of different strains indicated that strain 41, virtually, 
lacked the ability to infect epithelial cells. This strain gained an adhesive phenotype when it was grown in 
suspension rather than on a solid phase medium. Comparison of the outer membrane composition of the 
various strains by polyacrylamide gel electrophoresis (SDS-PAGE), revealed that the lipopolysaccharide 
(LPS) of ORT is composed of a heterogeneous set of small oligosaccharides. Strain 41 exhibited a 
different type of lipopolysaccharide from the other strains that were analyzed. Infection assays in the 
absence and presence of purified LPS, demonstrated that LPS inhibits the adherence of ORT to epithelial 
cells. This effect was strain specific, i.e. it was only seen when endogenous LPS was used. LPS exerted its 
infection inhibitory activity by influencing the adhesive properties of the bacteria rather than the host cell. 
This suggests that it may act as a receptor analogue.  
In Chapter 3, the interaction of ORT with macrophages was studied. This topic of investigation was 
chosen as pathological examination of ORT infected animals indicated a close association of the bacterium 
with macrophages. ORT efficiently adhered to and became ingested by both chicken and murine 
macrophages. After prolonged infection the bacteria appeared to be located inside intracellular vacuoles. 
LPS did not block the interaction of ORT with the macrophages in contrast to the ORT adhesion to 
epithelial  cells. This finding led to the conclusion that ORT carries multiple cell-type specific adhesins. 
The macrophage response to ORT was investigated using the production of nitric oxide as an 
inflammatory marker. NO exhibits bactericidal activity but it is also a regulator of the intracellular 
inflammatory signaling cascade and thus is a central molecule in innate host defenses. As described in 
Chapter 3,  ORT is able to induce the production of NO by macrophages. This stimulation did not require 
but was enhanced by rChIFNγ. This cytokine is thought to enhance NO production by increasing the 
activity of the key enzyme nitric oxide synthase (iNOS). The NO response stimulated by ORT differed 
from that induced by the Gram-negative bacteria E. coli and Salmonella enterica serovar Enteritidis (S. 
Enteritidis). The ORT response was slower and was not inhibited by the lipid A neutralizing agent 
polymixin B. This implies that the effect was not caused by LPS. In purified form, LPS derived from ORT 
did stimulate NO production. This indicates that the LPS of ORT is bioactive but apparently not in the 
context of the intact bacterium. Comparison of the NO response in chicken and mouse macrophages 
demonstrated that the stimulation of NO production by ORT was specific for chicken macrophages. 
Mouse macrophages were not susceptible to ORT but did respond to E. coli and S. Enteriditis. This 
differential responsiveness towards ORT may contribute to the host specificity of the ORT associated 
pathology, although it should be noted that large differences between macrophage populations exist. 
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Although the unraveling of bacteria-host cell interaction, with aid of in vitro infection model systems, 
is almost indispensable to unravel key determinants of infection, it does not take into account the 
significance of the complexity of natural infection. In Chapter 4, we addressed this issue and investigated 
the effect of serum on the interaction of ORT with various kinds of host cells. Both bovine and chicken 
serum inhibited ORT infection of epithelial cells in, a dose-dependent fashion. Further analysis 
demonstrated that the inhibition was caused via an effect of serum factors on the adhesive properties of the 
bacteria rather than on the host cells. Binding assays, using biotinylated isolated serum glycoproteins 
showed direct binding of multiple serum glycoproteins to the bacteria. Serum inhibition was not observed 
in the interaction of ORT with macrophages, supporting the idea that ORT carries multiple cell-type 
specific adhesins.  
The striking resemblance between the inhibitory effect of serum and LPS on the ORT-host cell 
interaction, led us to test the hypothesis that LPS and serum exerted their inhibitory effects through 
interaction with the same bacterial ligand. Competitive binding assays, in which the bacteria were first 
incubated with LPS or serum and subsequently with biotinylated isolated serum glycoproteins that bound 
to the bacteria, proved that the serum but not LPS competitively inhibited the binding of the biotinylated 
serum proteins to ORT. The difference between the effect of serum and LPS was confirmed by the 
difference in strain specificity of the inhibition and the differential inhibition of ORT-mediated 
haemagglutination. Based on these data it was concluded that serum and LPS inhibit ORT infection of 
epithelial cells via related but different mechanisms (Chapter 4).  
An additional noteworthy finding was the variable ability among ORT strains to cause 
haemagglutination of chicken red blood cells. One strain of ORT (strain 41) was unable to adhere to 
epithelial cells but did cause haemagglutination when the bacteria were grown onto solid phase media. 
When the bacteria were grown in suspension, opposite binding characteristics were observed. The 
apparent transition between phenotypes with different cell-type specificities (erythrocytes versus epithelial 
cells), dependent on the media growth conditions, may indicate the existence of a regulatory mechanism 
that enables the bacteria to adapt to various environmental niches encountered in the host. 
In Chapter 5, a transformation system for ORT is introduced that for the first time enables genetic 
modification of ORT. This is a major step as genetic manipulation of bacterial pathogens is nowadays an 
important factor in the identification and mutagenesis of putative virulence determinants and their 
regulatory components and in the development of attenuated strains with vaccine potential. The developed 
transformation system is based on a cryptic plasmid that is found in very few ORT isolates. This plasmid 
was completely sequenced and characterized. It contained up to 14 different open reading frames of which 
some appear to encode the proteins involved the transport of heavy metals across the membrane. 
Introduction of the origin of replication and several regulatory sequences of this plasmid (designated 
pOR1) into the vector  pGEM7, yielded a shuttle vector that replicated as an independent unit, in both E. 
coli and ORT. Introduction of an antibiotic resistance gene cfxA from Bacteroides vulgatus into the 
plasmid and the transfer of this plasmid to ORT rendered ORT resistant to the antibiotic. This confirmed 
that the plasmid could be utilized for bacterial genetics.  
As discussed in Chapter 6, the data presented in this thesis can be considered as a first, but major step 
in the unraveling of the pathogenesis of ORT infection. Identification of the multiple ORT adhesins and 
their corresponding host cell receptors, the mechanism by which LPS inhibit the infection in a strain-
specific fashion and the nature of the  inhibitory compounds in serum, are major future challenges that 
should provide a solid basis for the development of novel vaccines and complementary infection 
prevention strategies.   
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Samenvatting 
 
De bacterie Ornithobacterium rhinotracheale (ORT) is een belangrijke oorzaak van luchtweginfecties 
infectieziekten bij pluimvee. Onderzoek achteraf heeft aangetoond dat de bacterie waarschijnlijk 
afkomstig is van wilde vogels en ongeveer 20 jaar geleden voor het eerst problemen gaf in pluimvee. In 
deze dieren wordt de aanwezigheid van ORT niet alleen in verband gebracht met luchtweginfecties, maar 
ook met meer systemische infecties waaronder gewrichtsontstekingen en hersenvliesontsteking. Heden ten 
dage brengen ORT infecties aanzienlijke schade toe aan de pluimvee industrie. Bestrijding en preventie 
van de ziekte heeft dan ook grote prioriteit. Het bestaan van een infectie als gevolg van ORT wordt 
vastgesteld op basis van de aanwezigheid van niet-specifieke klinische symptomen in combinatie met 
isolatie van de bacterie en/of een positieve serologie. Behandeling van de ziekte wordt in toenemende 
mate bemoeilijkt door een wijd verbreide verworven resistentie van ORT tegen diverse antimicrobiële 
middelen. Er zijn intussen verschillende vaccins ontwikkeld. Deze beschermen echter slechts tegen een 
beperkt aantal serotypes. Het onderzoek beschreven in dit proefschrift is opgezet om de pathogenese van 
de infectie beter te begrijpen ervan uitgaande dat, op de lange termijn, gedegen wetenschappelijke kennis 
van de mechanismen die bijdragen tot het onstaan van een infectie de beste basis is voor het ontwikkelen 
van nieuwe vormen van infectie-interventie en preventie. 
 Een belangrijke stap in het onstaan van de meeste infecties is de hechting van de bacteriën aan het 
slijmvliesepitheel. In hoofstuk 2 wordt de initiële interactie van ORT met epitheelcellen beschreven. ORT 
heeft het vermogen om op een snelle en efficiënte wijze aan epitheelcellen te hechten. Afhankelijk van de 
toegediende dosis kunnen tot 80 gehechte bacteriën per epitheelcel worden waargenomen. Vergelijking 
van de hechtingseigenchappen van verschillende bacteriestammen toonde aan dat ORT stam 41 vrijwel 
niet in staat was om aan de epitheelcellen te hechten in tegenstelling tot de andere onderzochte stammen. 
Goede aanhechting van stam 41 kon echter worden geïnduceerd door de bacteriestam te groeien in 
vloeibare media in plaats van op agarplaten. Vergelijking van de samenstelling van geïsoleerde 
buitenmembranen van de verschillende bacteriestammen met behulp van SDS-electroforese toonde aan 
dat het lipopolysaccharide (LPS) van ORT bestaat uit een heterogene set van kleine oligosacchariden en 
dat stam 41 een ander LPS patroon heeft dan de andere stammen. In vitro infectie-experimenten met 
gekweekte epitheelcellen in de aan- en afwezigheid van gezuiverd LPS toonde aan dat LPS de hechting 
van ORT aan epitheelcellen remt. Dit effect was stam-specifiek, d.w.z. er trad alleen remming van de 
hechting op met LPS afkomstig van de eigen stam. Deze remming kwam tot stand door een effect van 
LPS op de bacterie; Preincubatie van de epitheelcellen met LPS gaf geen remming van de hechting. Deze 
bevindingen zouden erop kunnen wijzen dat LPS zich gedraagt als een receptor analoog en op deze wijze 
voorkomt dat bacteriële hechtingseiwitten aan LPS-achtige moleculen op de gastheercel kunnen binden. 
In hoofstuk 3 is het onderzoek naar de interactie tussen ORT en macrofagen beschreven. Pathologisch 
onderzoek van met ORT besmette dieren heeft aangetoond dat de bacteria zich ten tijde van een 
natuurlijke infectie veelvuldig in de nabijheid of wellicht zelfs in macrofagen bevindt. De resultaten 
beschreven in hoofdstuk 3 tonen aan dat ORT inderdaad hecht en wordt opgenomen door zowel 
gekweekte kippen- als muizenmacrofagen. De interactie van ORT met macrofagen werd niet geremd door 
het toevoegen van gezuiverd LPS. Dit in tegenstelling tot de interactie met de epitheelcellen. Deze 
bevinding wijst erop dat ORT verschillende cel-type specifieke hechtingseiwitten bezit. 
De reactie van macrofagen op het contact met ORT werd onderzocht aan de hand van de productie 
van nitric oxide (NO). NO is een zeer belangrijke molecuul bij het in gang zetten van de afweer van de 
gastheer en heeft bovendien bacterie-dodende eigenschappen. Zoals beschreven in hoofdstuk 3 leidt 
infectie met ORT tot een verhoogde productie van NO door de macrofagen. Dit effect vond reeds plaats in 
afwezigheid van recombinant kippen gamma-interferon (rChIFNγ), hoewel een krachtiger productie van 
NO werd gevonden in aanwezigheid van dit cytokine. rChIFNγ wordt gedacht de productie van NO te 
versterken door de activiteit van het sleutelenzym in de productie van NO, nitric oxide synthase (iNOS), te 
verhogen. De kinetiek van de inductie van NO door ORT was wezenlijk anders dan die welke werd 
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waargenomen bij de gram-negatieve bacteriële species E. coli and Salmonella enterica serovar Enteridis 
(S. Enteritidis). De toename in NO productie geïnduceerd door ORT was veel langzamer en niet geremd 
door het lipid A neutralizerende polimixin B. Dit in tegenstelling tot de stimulatie van de NO productie 
door de andere species. Deze vondst wijst erop dat de stimulatie van de NO productie door ORT niet 
wordt veroorzaakt door LPS. Toegediend in gezuiverde vorm was LPS echter wel in staat de productie 
van NO door macrofagen te verhogen. Dit wijst erop dat het LPS van ORT biologisch actief is, maar niet 
in de vorm zoals die aanwezig is in de intacte bacterie. Vergelijking van de NO productie door kippen- en 
muizenmacrofagen toonde aan dat de stimulatie van de NO productie door ORT specifiek was voor 
kippenmacrofagen. Muizenmacrofagen gaven geen toename in NO productie te zien, hoewel deze cellen 
wel reageerden op E. coli and S. Enteriditis. Het verschil in reactie van kippen- en muizenmacrofagen op 
ORT zou kunnen bijdragen aan de gastheerspecifieke pathologie van ORT infecties. Deze conclusie moet 
echter nog verder worden bevestigd aangezien de resultaten werden verkregen met gekweekte macrofagen 
en er in vivo waarschijnlijk grote verschillen bestaan tussen verschillende populaties van macrofagen. 
Hoewel voor het ontrafelen van de bacterie-gastheer interactie het gebruik van in vitro infectiemodel 
systemen in de praktijk de meest succesvolle strategie is gebleken, gaat deze aanpak voorbij aan de 
complexiteit van de natuurlijke infectie. Het belang hiervan blijkt uit de resultaten van de experimenten 
beschreven in hoofdstuk 4. In dit hoofdstuk werd het effect van serum op de interactie van ORT met 
verschillende typen gastheercellen onderzocht. Er werd aangetoond dat zowel runder- als kippenserum in 
staat is de hechting van ORT aan  epitheelcellen volledig te remmen. Nader onderzoek toonde aan dat dit 
effect werd veroorzaakt door een interactie van serumcomponenten met de bacterie. 
Bindingsexperimenten waarbij gebruik werd gemaakt van gezuiverde gebiotinyleerde serum 
glycoproteinen toonde directe binding van serumeiwitten aan de bacteria aan. De remming van de 
hechting door serum werd niet gevonden voor de interactie van ORT met macrofagen. Dit ondersteunt de 
bovengenoemde hypothese dat ORT beschikt over verschillende typen hechtingseiwitten. 
Op grond van de opvallende overeenkomst tussen de remmende effecten van serum en LPS op de 
hechting van ORT aan epitheelcellen werd de hypothese ontwikkeld dat LPS en serum hun remmende 
effect wellicht zouden kunnen bewerkstelligen door een interactie met hetzelfde bacteriële ligand. 
Competitieve bindingsexperimenten waarin de bacterie eerst werd gepreincubeerd met LPS of serum en 
vervolgens met gezuiverde gebiotinyleerde serumeiwitten toonde echter aan dat serum, maar niet LPS de 
binding van de serumeitwitten aan de bacterie remde. Het bestaan van een verschil in de mechanismen via 
welke serum en LPS de hechting aan epitheelcellen remmen, werd verder bevestigd door het verschil in 
stam-specificiteit van de remming: LPS remde alleen de aanhechting van de eigen stam, terwijl de 
remming door serum niet stam-specfiek was. Op grond van deze resultaten werd geconcludeerd dat serum 
en LPS de ORT infectie van epitheelcellen remmen via wellicht verwante, maar toch verschillende 
mechanismen (Hoofdstuk 4). 
Een andere opvallende bevinding beschreven in hoofdstuk 4 was de variatie in het vermogen van 
verschillende ORT stammen om kippenerythrocyten te agglutineren. Een van de stammen (stam 41) die, 
na kweek op agarplaten, nauwelijks het vermogen bezat om aan epitheelcellen te hechten vertoonde sterke 
haemagglutinatie activiteit. Echter wanneer de bacteriestam werd gegroeid in vloeibaar medium, werden 
geheel tegenovergestelde eigenschappen gevonden, d.w.z. de bacteriën hechtten nu sterk aan 
epitheelcellen maar hadden hun vermogen tot haemagglutinatie nagenoeg verloren. Deze klaarblijkelijke 
overgang tussen fenotypen met een verschillende celtype specificiteit (erythrocyt versus epitheelcel) 
afhankelijk van de groeiomstandigheden, zou kunnen wijzen op het bestaan van een regulatiemechanisme 
dat de bacteriën in staat stelt zich aan te passen aan de verschillende milieu's zoals die bestaan in de 
gastheer. 
In hoofdstuk 5 wordt voor het eerst een methode om ORT genetisch te transformeren beschreven. 
Deze resultaten zijn van groot belang aangezien genetische manipulatie van bacteriën hoe langer hoe meer 
van belang blijkt te zijn voor het identificeren van virulentie-eigenschappen van bacteriën en voor de 
ontwikkeling van vaccins. De ontwikkelde methode van genetische transformatie is gebaseerd op een 
cryptisch plasmide dat aanwezig bleek in enkele ORT stammen. De volledige DNA volgorde van dit 
plasmide (pOR1) werd bepaald en geanalyseerd. Het plasmide bleek 14 open reading frames te bezitten 
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waarvan een aantal lijken te coderen voor eitwitten die betrokken zijn bij het transport van zware metalen 
over de bacteriemembraan. Van groter belang is echter dat dit plasmide kon worden gebruikt voor het 
ontwikkelen van een shuttle vector. Door introductie van de plasmide replicatie oorsprong en enkele 
regulerende sequenties van  (pOR1) in de vector pGEM7 onstond een shuttle vector die zich vermeerderde 
in zowel E. coli als ORT. Introductie van het antibiotica resistentie gen cfxA, afkomstig van Bacteroides 
vulgatus, in de shuttle vector en overdracht van deze vector van E. coli naar in ORT, resulteerde in 
cefoxitine resistente ORT. Dit bevestigde dat de ontwikkelde shuttle vector geschikt is voor genetische 
modificatie van ORT. 
 Zoals aangegeven in hoofdstuk 6, kunnen de resultaten beschreven in dit proefschrift worden 
beschouwd als een eerste, maar belangrijke stap in het ontrafelen van het onstaan van ORT infecties. De 
identificatie van de verschillende bacteriële hechtingseiwitten en hun receptoren op de gastheercellen, van 
het mechanisme via welk LPS de hechting kan remmen, en van de aard van de infectie-remmende stoffen 
in serum zijn belangrijke uitdagingen voor toekomstig onderzoek. Kennis van deze factoren zal hopelijk 
een stevige basis zijn  voor het onwikkelen van nieuwe vaccins en andere vormen van infectie-preventie. 
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บทสรปุ 
 
ตั้งแตมีการคนพบแบคทีเรีย ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย (Ornithobacterium rhinotracheale) เมื่อ ๑๐ 
ปที่ผานมาพบวาแบคทีเรียชนิดนี้ สามารถกอโรคไดในไกและไกงวง โดยแบคทีเรียชนิดนี้ปรับตัวจากการกอโรคในนกปา 
มายังไกเมื่อประมาณ ๒๐ ปที่ผานมา ในไก ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย สามารถกอใหเกิดอาการผิดปกติ 
ของระบบทางเดินหายใจและการติดเชื้อตามระบบ รวมทั้งขออักเสบและสมองอักเสบ ปจจุบัน ออรนิโธแบคทเีรียม ไรโน-
เทรเคียอัลเลย เปนสาเหตุใหเกิดความสูญเสียทางเศรษฐกิจอยางมากตออุตสาหกรรมการเลี้ยงสัตวปกจึงมีความพยายาม 
ในการควบคุมและปองกันโรค การวินิจฉัยการติดเชื้อ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย มักอาศัยอาการทางคลินิก 
ซึ่งไมเฉพาะเจาะจงกับโรค รวมกับการแยกเชื้อแบคทีเรีย และ/หรือ รวมกับการใชวิธีทดสอบทางซีร่ัมวิทยา แตตัวเชื้อก็ยังมี-
โอกาสหลุดรอดจากการวินิจฉัยไดบอยครั้ง การรักษาโรคคอนขางมีความซับซอน เนื่องจากเชื้อแบคทีเรียชนิดนี้มีความ-
สามารถในการตานทานยาปฏิชีวนะไดอยางกวางขวาง แมมีการพัฒนาวัคซีนชนิดตางๆ ขึ้นมาก็พบวามีความสามารถ 
ในการปองกันโรคไดอยางจํากัดเฉพาะซีโรไทป การศึกษาในปจจุบันออกแบบเพื่อใหเกิดความเขาใจ ในพยาธิกําเนิด-
ของการติดเชื้อ เนื่องดวยความเชื่อที่วา ความรูทางวิทยาศาสตรที่เขมแข็งในกลไกของการติดเชื้อ เปนพื้นฐานที่สําคัญที่สุด 
ในการพัฒนานวัตกรรมของกลวิธีในการปองกันและควบคุมโรคในระยะยาว 
ในบทที่ ๒ เปนการศึกษาในระดับเซลลของปฏิสัมพันธปฐมภูมิของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
กับเซลลเยื่อบุ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย สามารถเกาะยึดกับเซลลเยื่อบุไดอยางมีประสิทธิภาพ ซึ่งแปรผัน 
ตามปริมาณของเชื้อ โดยพบจํานวนแบคทีเรียสูงถึง ๘๐ แบคทีเรียตอเซลล การเปรียบเทียบคุณสมบัติการเกาะยึดเซลล 
ของแบคทีเรียเสตรนตางๆ พบวาเสตรน ๔๑ ขาดความสามารถในการติดเชื้อตอเซลลเยื่อบุ เสตรนนี้มีลักษณะฟโนไทป 
ในการเกาะยึดเมื่อไดรับการเพาะเชื้อในอาหารเลี้ยงเชื้อชนิดเหลวแทนการเพาะเชื้อบนผิวอาหารวุน การเปรียบเทียบ 
สวนประกอบของเปลือกชั้นนอกของเยื่อหุมเซลลของแบคทีเรียเสตรนตางๆ โดยวิธี sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) พบวา lipopolysaccharide (LPS) ของ ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย ประกอบดวยกลุม oligosaccharides เล็กๆ ที่มีขนาดแตกตางกัน เสตรน ๔๑ แสดง LPS ที่แตกตางไป 
จากเสตรนอื่นที่ทําการวิเคราะห การทดลองการติดเชื้อที่มีและไมมี LPS แสดงใหเห็นวา LPS ยับยั้งการเกาะยึดของ 
ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ตอเซลล เยื่อบุ จากการทดลองนี้แสดงลักษณะความเฉพาะของเสตรน คือ 
การยับยั้งการเกาะยึดของแบคทีเรียตอเซลล โดยพบเฉพาะ LPS ที่แยกจากแบคทีเรียเสตรนเดียวกัน และพบวา LPS 
มีอิทธิพลตอแบคทีเรียมากกวาเซลลเยื่อบุ ซึ่งแสดงใหเห็นวาแบคทีเรียนาจะมีตัวรับตอ LPS 
ในบทที่ ๓ เปนการศึกษาปฏิสัมพันธของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย และมาโครฟาจ การศึกษาในบทนี้ 
สืบเนื่องมาจากผลทางพยาธิวิทยาของสัตวที่ติดเชื้อ มักพบความสัมพันธรวมกันระหวางแบคทีเรียและมาโครฟาจ โดยพบ-
วา ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย มีประสิทธิภาพในการเกาะยึดและถูกกลืนทําลายโดยมาโครฟาจ ทั้งที่มี- 
ตนกําเนิดจากสัตวปกและหนู และเมื่อเพิ่มระยะเวลาในการทดลองการติดเชื้อจะพบแบคทีเรียอยูภายในแวคคิวโอลส 
ภายในเซลลมาโครฟาจ ปฏิสัมพันธระหวาง ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย และมาโครฟาจไมถูกยับยั้งโดย LPS 
ซึ่งตรงขามกับการติดเชื้อของเซลลเยื่อบุ การคนพบนี้นําไปสูขอสรุปที่วา ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
มีแอดฮีซินเฉพาะกับเซลลหลายชนิด การศึกษาการตอบสนองของมาโครฟาจตอ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
โดยอาศัยผลผลิตของไนตริก ออกไซด (Nitric Oxide) ในฐานะที่เปนตัวบงชี้ (marker) ของการอักเสบ ไนตริก ออกไซด 
มีความสามารถในการทําลายแบคทีเรีย และยังมีความสามารถในการเปนตัวควบคุม (regulator) ของลําดับสัญญาณ 
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(signaling cascade) ของการอักเสบอีกทั้ง ไนตริก ออกไซด ยังเปนโมเลกุลหลักของการปองกันโดยกําเนิดของเซลล 
เจาบาน ตามที่ไดอธิบายในบทที่ ๓ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย สามารถเหนี่ยวนําการผลิต ไนตริก ออกไซด 
จากมาโครฟาจ การกระตุนนี้ไมตองการอินเตอรเฟยรอนแกมมาสังเคราะหของไก (recombinant chicken inteferon 
gamma, rChIFNγ) แต rChIFNγ สามารถเพิ่มผลผลิต ไนตริก ออกไซด ได การที่ไซโตไคนชวยเพิ่มการผลิต ไนตริก 
ออกไซด อาจเนื่องจากการไปเพิ่มกิจกรรมของเอนซัยมตัวสําคัญ คือ ไนตริก ออกไซด ซินเทส (nitric oxide synthase) 
การตอบสนองของ ไนตริก ออกไซด ตอการกระตุนโดย ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย แตกตางจาก 
การเหนี่ยวนําดวยแบคทีเรียแกรมลบชนิดอื่น คือ อี. โคไล และ ซัลโมเนลลา เอ็นเตอริกา ซีโรวาร เอ็นเตอรรัยติดิส (S. 
Enteritidis) โดยการตอบสนองของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ลดลงและไมถูกยับยั้งโดยโพลีมิกซิน บี 
ซึ่งมีคุณสมบัติในการหักลางฤทธิ์ของลิปด เอ จากผลการทดลองนี้ แสดงใหเห็นวาการกระตุนการผลิต ไนตริก ออกไซด 
ไมไดเกิดจาก LPS ของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย เพียงลําพัง โดยพบวา LPS บริสุทธที่สกัดไดจาก 
ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย กระตุนการผลิต ไนตริก ออกไซด ซึ่งแสดงใหเห็นวา LPS ของ ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย มีฤทธิ์ทางชีวภาพ เปรียบเทียบจากการตอบสนองการผลิต ไนตริก ออกไซด ในมาโครฟาจจากไกและ-
หนู แสดงใหเห็นวาการกระตุนการผลิต ไนตริก ออกไซด โดย ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย มีความเฉพาะตอ 
มาโครฟาจจากไก โดยพบวา มาโครฟาจจากหนูไมตอบสนองตอการกระตุนดวย ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
แตตอบสนองตอการกระตุนดวย อี. โคไล และ S. Enteritidis การตอบสนองที่แตกตางกันของ ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย นี้อาจเกิดเนื่องจากความเฉพาะเจาะจงของเซลลเจาบานรวมกับการเกิดพยาธิสภาพ อยางไรก็ตาม 
ควรตั้งขอสังเกตวา มีความแตกตางอยางมากระหวางมาโครฟาจชนิดตางๆ  ในการตอบสนองการกระตุนดวย ออรนิโธ-
แบคทีเรียม ไรโนเทรเคียอัลเลย    
แมเปนที่แนใจไดวาปฏิสัมพันธระหวางเซลลเจาบานและแบคทีเรีย ชวยในการเสริมความเขาใจในรูปแบบการติดเชื้อ 
ในหลอดทดลอง ซึ่งมีความจําเปนในการคนพบกุญแจสําคัญในการติดเชื้อ แตการติดเชื้อในหลอดทดลองอาจไมสัมพันธ 
กับการติดเชื้อในธรรมชาติ ในบทที่ ๔ ไดกลาวถึงความสําคัญในประเด็นนี้และทําการศึกษาผลของซ ีร่ัมตอปฏิสัมพันธของ 
ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย กับเซลลเจาบานชนิดตางๆ พบวาซีร่ัมจากโคและไกสามารถยับยั้งการติดเชื้อ 
ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ของเซลลเยื่อบุ โดยการยับยั้งนี้มีความสัมพันธกับความระดับเขมขนของซีร่ัม 
การวิเคราะหตอมาแสดงใหเห็นวา การยับยั้งนี้มีสาเหตุจากผลของปจจัยในซีร่ัมตอคุณสมบัติในการเกาะยึดของแบคทีเรีย 
มากกวาผลที่มาจากเซลลเจาบาน การเชื่อมไบโอตินเขากับซีร่ัมไกลโคโปรตีน ไดแสดงใหเห็นถึงการจับกัน โดยตรงระหวาง 
ซีร่ัมไกลโคโปรตีนตางๆ กับแบคทีเรีย การยับยั้งโดยซีร่ัมนี้ไมพบในปฏิสัมพันธระหวาง ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย กับมาโครฟาจ ซึ่งเปนการสนับสนุนความคิดที่วา ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ประกอบดวย 
ความสามารถในการเกาะยึดที่เฉพาะตอเซลลชนิดตางๆ  
ความคลายคลึงที่นาสนใจระหว างผลของการยับยั้งโดยซีร่ัมและ LPS ตอปฏิสัมพันธระหวาง ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย กับเซลลเจาบาน สงผลตอการทดสอบสมมติฐานวา LPS และซีร่ัมอาศัยผลในการยับยั้งการเกาะยึด 
โดยผานไลแกน (ligand) ของแบคทีเรียชนิดเดียวกันหรือไม วิธีการแขงขนัการเกาะยึด โดยการบม (incubate) แบคทีเรีย 
กับ LPS หรือซีร่ัม และตอมาบมแบคทีเรียดวยไบโอตินเชื่อมกับซีร่ัมไกลโคโปรตีนซึ่งเกาะกับผิวแบคทีเรีย ความแตกตาง 
ระหวางผลของซีร่ัมและ LPS ถูกยืนยันโดยอาศัยความแตกตางของความเฉพาะของเสตรนของการยับยั้ง และการยับยั้ง 
ที่แตกตางของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ดวยวิธีการตกตะกอนกับเม็ดเลือดแดง (haemagglutination) 
จากขอมูลเหลานี้ สามารถสรุปไดวา ซีร่ัมและ LPS ยับยั้ง การติดเชื้อ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
ตอเซลลเยื่อบุ ดวยกลไกที่แตกตางกัน (บทที่ ๔) 
บทสรุป  
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การคนพบอื่นจากการศึกษานี้ คือ ความเแปรผันระหวางเสตรนตางๆ ของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
ตอการตกตะกอนกับเม็ดเลือดแดงของไก ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย เสตรน ๔๑ ไมสามารถเกาะยึดกับเซลล- 
เยื่อบุ แตสามารถตกตะกอนกับเม็ดเลือดแดงเม ื่อทําการเพาะเชื้อแบคทีเรียบนผิวอาหารวุน แตเมื่อทําการเพาะเชื้อ-
แบคทีเรียในอาหารเหลวสามารถสังเกตพบลักษณะตรงขามที่กลาวมา โดยพบการเปลี่ยนของฟโนไทปกับความเฉพาะ 
ของชนิดเซลลที่แตกตางระหวางเม็ดเลือดแดงกับเซลลเยื่อบุ โดยขึ้นกับสภาพในการเพาะเลี้ยงเชื้อแบคท ีเรียบงชี้ถึง 
การปรากฎของกลไกในการควบคุม ซึ่งสงเสริมใหแบคทีเรียปรับตัวตอการเปลี่ยนแปลงของสภาพแวดลอมตอเซลลเจาบาน 
ในบทที่ ๕ เปนการศึกษาระบบการสงผานสารพันธุกรรม (transformation system) ของ ออรนิโธแบคทีเรียม 
ไรโนเทรเคียอัลเลย ซึ่งเปนการศึกษาการเปลี่ยนแปลงทางพันธุกรรมของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย  เปนครั้ง-
แรก ถือเปนกาวยางที่สําคัญของการจัดการทางพันธุกรรมของแบคทีเรียกอโรค ซึ่งปจจุบันพบวามีความสําคัญในการ-
พิสูจนและการเปลี่ยนแปลงของตัวกําหนดความรุนแรงที่เปนที่ยอมรับและเปน สวนประกอบในการควบคุมการกอโรคของ 
แบคทีเรีย และการพัฒนาเสตรนแบคทีเรียเพื่อศักยภาพในการนําไปใชเปนวัคซีน การพัฒนาระบบการสงผานสาร-
พันธุกรรมนี้ โดยการศึกษาพลาสมิด (plasmid) ซึ่งพบในไมกี่เสตรนของ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
พลาสมิดนี้ไดทําการสืบหาลําดับเบส (sequence) ที่สมบรูณพรอมกับจําแนกยีนชนิดตางๆ โดยพบวาพลาสมิดนี้ประกอบ 
ดวยกรอบการอานยีน (open reading frames) ๑๔ จุดที่แตกตางกัน โดยบางสวนนั้นไดใหรหัส (encode) ของโปรตีน 
ซึ่งเกี่ยวพันกับการขนสงโลหะหนักขามเยื่อหุมเซลล การนําบางสวนของลําดับเบสท ี่เกี่ยวของกับการเพิ่มจํานวนและการ- 
ควบคุมการเพิ่มจํานวนของพลาสมิดนี้ใสในเวคเตอร pGEM7 ทําใหไดเวคเตอรกระสวย (shuttle vector) ซึ่งใหชื่อวา 
pOR1 ซึ่งสามารถเพิ่มจํานวนในฐานะที่เปนหนวยอิสระทั้งในเซลล อี. โคไล และ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย 
การนํายีนที่ความคุมการตอตานยาปฏิชีวนะ cfxA จาก แบคทีรอยเดส วาลกาตัส (Bacteroides vulgatus) ไปใสใน 
พลาสมิดชวยทําใหพลาสมิดนี้มีความตานทานตอยาปฏิชีวนะ ซึ่งยืนยันวาพลาสมิดนี้สามารถใชสําหรับการศึกษา 
พันธุกรรมของแบคทีเรียได 
ในบทที่ ๖ เปนบทวิจารณ โดยขอมูลที่ปรากฎในวิทยานิพนธนี้ ถือไดวาเปนกาวแรกแตเปนกาวสําคัญ ในการศึกษา 
พยาธิกําเนิดของการติดเชื้อ ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย ซึ่งไมสามารถโตแยงได การพิสูจนพบสารเกาะยึด 
ออรนิโธแบคทีเรียม ไรโนเทรเคียอัลเลย หลายชนิดและความสื่อสารกับตัวรับของเซลลเจาบาน กลไกที่ LPS ยับยั้ง-
การติดเชื้อในรูปแบบเฉพาะตอเสตรน และธรรมชาติของสวนประกอบการยับยั้งในซีร่ัมเปนการทาทายที่สําคัญในอนาคต 
วาสามารถใชความรูเหลานี้ในการผลิตวัคซีนชนิดใหมที่มีประสิทธิภาพในการปองกันโรค 
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